The Quest for a Perfect Death.: Thoughts on Death and Dying in the Future by Zimmermann-Acklin, Markus
 
 
 
 
Proceedings from the Societas Ethica 
Annual Conference 2011, The Quest  
for perfection. The Future of 
Medicine/Medicine of the future 
 
August 25–28, 2011, 
Universita della Svizzera Italiana,  
Lugano, Switzerland 
 
 
 
Editors 
 
Göran Collste and Arne Manzescheke 
 
 
 
 
 
Societas Ethica Annual Conferens, Issue 48 
Copyright  
The publishers will keep this document online on the Internet – or its possible replacement –
from the date of publication barring exceptional circumstances.  
The online availability of the document implies permanent permission for anyone to read, 
to download, or to print out single copies for his/her own use and to use it unchanged for non-
commercial research and educational purposes. Subsequent transfers of copyright cannot 
revoke this permission. All other uses of the document are conditional upon the consent of the 
copyright owner. The publisher has taken technical and administrative measures to assure 
authenticity, security and accessibility. According to intellectual property law, the author has 
the right to be mentioned when his/her work is accessed as described above and to be 
protected against infringement.  
For additional information about Linköping University Electronic Press and its procedures 
for publication and for assurance of document integrity, please refer to its www home page: 
http://www.ep.liu.se/.  
 
 
 
 
 
 
 
 
Linköping Electronic Conference Proceedings, No74  
Linköping University Electronic Press  
Linköping, Sweden, 2013 
ISSN: 1650-3686 
eISSN: 1650-3740 
URL: http://www.ep.liu.se/ecp_home/index.en.aspx?issue=074 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© The Authors, 2013 
  
The Annual Conference of The Societas Ethica  
2011  
 
August 25-28, 2011 
Lugano, Switzerland 
 
The Quest for perfection  
The Future of Medicine / Medicine of the future 	  	  
Theme	  and	  guiding	  question	  	  
There is all over the world a sort of fever affecting all the research fields related, closely or somewhat loosely, 
with human health issues. Some of them – cloning, therapeutic cloning, stem cell therapy, human enhancement, 
etc. –  arise fierce and controversial public debates. At the same time, a concern can be felt worldwide that 
tomorrow’s medicine might well become more and more « dual », the advanced health devices threatening to 
become the privilege of a small whealthy minority,  or at least excluding the vast majority of the poor and the 
low middle class. Furthermore, there are even greater disparities between wealthy and poor nations in access to 
health care and in the level of protection available to members of the latter’s population in a medical context. 
The theme of rationing health care has been ongoingly gaining in prevalence over the two to three last decades in 
the public debates, causing many to express worries about the ability of our health system to provide both 
efficiency and justice in health care. But, among all the new health care devices, are there not some which could 
be efficient both in terms of improvement of the management of patients’ health and of a just allocation of care ? 
Besides, not only emerge concerns linked with the development of new technologies in health care, but also in 
connection with the impact of social-political transformations onto the medical relationship : what are in this 
context the doctor-patient relationship in regard to autonomy and gender ? Should we be free to use or not to use 
these new technologies ? Might not the « quest for perfection » develop into a duty of perfection ? And, with the 
improvement of the therapeutic power to prolong human life, are we to think of assisted suicide as the future of 
death ? 
These are some of the issues that this conference wants to adress from an ethical perspective and with rigour. 
To enrich our discussions also medical and life science praticioners willing to reflect ethically on moral 
questions of health issues in their professional life and politicians faced with ethical decisions in the domain of 
health are welcome to participate. 	  	  
Call for papers 
To achieve this goal, we invite everybody active in academia working in bio-medical ethics and related fields to 
join our academic discussion by handing in an abstract.  This invitation is intended also to medical and life 
science praticioners willing to reflect ethically on health issues. 
More precisely, we invite you to submit us a proposal of max. 4'000 caracters in which you describe the question 
you want to address as well as some indications concerning the data and the method through which you intend to 
deal with your problem. The issue you raise may be related to one of the subtopic mentioned below or on any 
other topic of your interest – there will be a session channel reserved for contributions which do not bear on the 
theme of the annual conference. The decisive point is that you show a broad knowledge of the field and/or a 
great sense of relevance in the way you formulate your interrogation.  
The head topics on which we expect your proposal are : 
• Justice in the future of health: economic, demographic and global issues  
• Personal health monitoring 
• Human enhancement 
• Gender and medicine 
• Autonomy in care and medicine 
• End of life ethical issues 
• Open channel for papers not on the conference theme 	  	  
• Justice in the future of health: economic, demographic and global issues  
The underlying concern here is that a two (or more) classes medicine might be more and more tomorrow’s health 
care reality : at the global as well as at the local level evidences of an increasing gap between the medicine for 
the wealthy and the one for the poor seem to be piling in. Does the rationing of health care  necessarily mean the 
exclusion of care of the ones who do not have the financial resources to pay for it ? Is this market driven 
selection ethically just ? Does not a « just allocation of resources » in the field of health care require another 
model ? If « just » means « more equal access regardless of financial resources », is just allocation of resources 
in health care irreconcilable with a performant medicine ? Could we not – should we not – reconcile efficiency 
and justice ? 
 
• Personal health monitoring 
With the help of monitoring devices, sensors, robots and information technology, future medicine will move 
from hospitals to patients’ homes. Other actors, like insurances or other interested parties could have the 
opportunity to gain information about the patient : Will the emerging health care at a distance pose a threat to 
patient privacy, personal autonomy, the relation between doctor and patient, and perhaps even to personal 
identity? Can distant health care allow underprivileged regions to have access to medical expertise and hence 
contribute to justice ? 
 
• Human Enhancement 
Human enhancement challenges the traditional medical goals ; therefore one has to ask how the status and the 
mission of  medicine will be modified by the fostering of enhancement technologies. Were cosmetic surgery, 
anabolic steroids, and growth hormones to become usual social practices, how would medicine and society 
evolve under the pressure of moods elevators, cognitive enhancers, somatic or germinal genetic recombination, 
brain engineering and intracorporeal prosthesis ? 
 
• Gender and medicine : 
Ethical questions concerning the issue of « gender and medicine » refer to research, health care organization, and 
treatment : How can gender issues get inserted into research without enforcing gender stereotyping ? Do 
biological sexes shape moral decisions ? How is the patient-doctor-support staff relation affected by gender 
issues ?   Do new biotechnological developments have differential impacts on gender ? Which implicit moral 
framework do they follow ? Which ethical argumentations have to be developed concerning gender and 
medicine ? 
 
• Autonomy in care and medicine 
In the field of care and medical treatment autonomy is a core issue. On a very basic level the concept of 
autonomy itself has to be questioned: What does autonomy of the person really mean? How is it related to the 
social conditions of human life? How is it legally constructed, what are the determining social, economic, 
political and cultural factors of autonomy? What is the ethical impact of autonomy beyond a merely 
individualistic reading of the term? On this base special questions have to be asked: What does autonomy mean 
in the patient-doctor-relation? How can patients be enabled to take autonomous decisions in face of a rapidly 
developing high tech medicine? What is the impact of social expectations and economic pressure on personal 
behaviour and decision-making in health issues? What are the conditions of communication and treatment to be 
guaranteed within the medical and care system in order to empower and encourage real autonomy despite the 
asymmetric relations between the ‘experts’ – the caring person or doctor – and the one who receives care or 
medical treatment?  
 
• End of life ethical issues 
End of life issues involve many questions ranging from withholding and withdrawal of treatment, care for the 
dying person, his-her place in society, how new medical technologies affect the way patients are treated and kept 
alive, by who and how life-and-death-decisions will be made, etc. All these questions boil down, maybe, to this 
one: Do the new emerging technologies change our thinking about the good death or end of life? Do they push 
us to think of death as either an accidental failure (of medicine, of our power on our lives, etc.) or as deliberate 
choice? 	  	  
To take part to the cfp application, Please send in the two following separate documents : 
• Your name, first name, email address, institutional address + the title of your abstract + in case, your 
application to the young scholar award (see condition on webpage) ; + the precision of the headtopic 
under which your abstract falls 
• Your abstract (max. 4'000 cars ; we do not accept full papers) without your name on it (this anonymised 
document will be sent to the reviewers who will be in charge to assess its academic worth and 
relevance), in pdf format (preferably) or word 
 
Please do note that the criteria for acceptance of a paper refer mainly to the masterhood in designing an 
ethically relevant question and in leading an ethical discussion. 
 
 
Deadline for the submission of your abstract : 31 March 2011 
To be sent to : cehrwein@bluewin.ch 	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Discourses and Practices of Democratic Transhumanism 
 
Amy Michelle DeBaets 
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Abstract 
Transhumanism is a sociopolitical movement that seeks to transform human beings into beings 
beyond the human condition through various technological means. Within this broader 
movement stand the democratic transhumanists, or technoprogressives, who believe that a social 
safety net and broad access to transhuman and related medical technologies are critical to both 
justice and the success of the transhumanist project. Feminists engaged in technological and 
political analysis often have much in common with technoprogressivism, but there are also 
significant points of disagreement. A liberal feminist ethical analysis of democratic 
transhumanism will highlight areas of both agreement and disagreement and will provide a 
potential roadmap for how to ethically engage the future of transhuman technologies. 
 
Keywords: feminism, transhumanism, democracy, technoprogressivism, technology, bioethics 
 
2 
Human beings are beginning to have options in healthcare that make them, in some distinct 
ways, “better” – not just having a lack of illness, but becoming stronger or smarter, more 
beautiful or long-lived, than they are without technological intervention. Some of these 
technologies already exist, while others are being developed every day. Alongside these 
technological innovations are conversations about the ethical issues involved in both their 
development and distribution – what technologies should be developed, who should pay to 
develop the technologies, who should have access to them, and what avenues of research might 
be displaced in their development. 
This paper will provide a brief outline of the contemporary socio-political movement 
known as transhumanism, explain some of its various forms and their respective politics, and 
provide a both sympathetic and critical ethical commentary on that movement. I will focus my 
ethical analysis particularly on democratic transhumanism, sometimes also called techno-
progressivism, which I have found to be the most ethically constructive form of transhumanism, 
though it still has some serious flaws. My comments will be largely derived from a perspective I 
describe as feminist, though the majority of my analysis will not directly address questions of 
gender. I will attempt to highlight some points of basic agreement that I see between 
contemporary liberal, democratic feminism and the sub-movement of democratic 
transhumanism. I will also discuss some aspects of democratic transhumanism that I believe can 
and should be challenged and some insights from feminist thought that can provide constructive 
alternatives in moving toward the future of technology. 
The feminist perspective I hope to bring to bear on this discussion is one based in the 
history of feminist reflection on issues of gender, embodiment, political power, and the common 
good, as feminist analysis has never been only about gender. Likewise, there are a variety of 
different types of feminist perspectives, of which I am representing only one. It is my contention 
here that feminism provides a history of critical reflection on sometimes under-considered topics, 
particularly the place and function of the body in human life, power and political representation, 
justice and the common good. 
The feminism that contributes to my analysis here is one that stands within the broader 
liberal democratic tradition of politics. While I believe that there are legitimate criticisms of 
liberal democracy and the formation of the liberal subject that arise within feminist analysis, I 
also believe that liberal democracy represents the best available option for contemporary political 
life in a pluralistic society. Liberal democracy is coupled in this view with social democracy and 
a well-regulated, if free, market system. The balancing of market economics with a social safety 
net, and individual freedom with the common good, are things I find important as a feminist and 
will weigh heavily in my analysis of transhumanist discourse and practice. Culturally, the 
feminism presented here is one that is Western in perspective but transnational in consideration 
and scope. While many aspects of transhumanism have proved appealing to affluent Westerners, 
it has not had anywhere near the same traction in the global South, for reasons I will consider 
shortly. This feminist analysis will explore the role of the body in democratic transhumanist 
discourse and will indicate both a skepticism and hopefulness regarding current political, 
economic, and social structures in developing and utilizing emerging technologies.  
3 
Betty Friedan’s 1963 classic, The Feminine Mystique, described what she called, “the 
problem that has no name,” referring to the discontent with their condition that many women of 
her era felt when they were socially expected to find happiness and fulfillment by staying at 
home and raising children instead of pursuing careers.1 In response to this “strange stirring” and 
“sense of dissatisfaction” that resulted from women’s “painfully giving up [their] dreams,” she 
called for dramatic changes in society in order to free women from the confines of household 
drudgery.2 Transhumanism likewise calls for radical social changes in order to free people from 
the confines of a limited existence within the human condition, offering the opportunity, through 
advanced technology, to achieve greater happiness, intelligence, and longevity. 
Transhumanism is a socio-political movement that has developed in recent years in 
supporting human efforts to transcend the human condition through a variety of technological 
means. Transhumanism has its roots in Enlightenment positivist and rationalist thought and often 
holds to a narrative of ongoing scientific (and sometimes moral) progress and development from 
primitive to advanced technological societies. The term transhumanism appears to have been 
coined in the 1950s by Julian Huxley and serves as a portmanteau for transitional human – the 
human who begins to move beyond one’s limits toward a posthuman state. 
Transhumanists are not all the same, and there are a variety of sub-movements that vary 
substantially based on their respective politics and visions of the future. Many of the early 
transhumanists came from the Californian technolibertarian groups of the 1980s and 1990s. 
These men (and they were men) were entrepreneurs and early adopters of information 
technologies. They gathered together over optimism for the technological future of humanity, 
shared suspicion of any governmental regulation of technological development, and Hayekian-
libertarian anarcho-capitalist politics3. They changed their names to “cool” high-tech ones and 
embraced the possibilities for their own boundless technological self-transformation.4 The 
libertarian transhumanists adopted the term “extropians” for themselves – with the idea of 
extropy as the opposite of entropy.5 Max More founded the Extropy Institute in the early 1990s, 
which served as an organizational and online hub for like-minded transhumanists. 
On the other side of the political spectrum stand the social-democratic transhumanists, or 
technoprogressives. Arising primarily from Europe rather than California, these transhumanists 
valued the ideals of equal access to technology and a basic social safety net for all persons. 
Those democratic transhumanists rejected the libertarian politics of the extropians and started 
their own organization – the World Transhumanist Association – in 1998, to foster both a more 
left-wing political transhumanism as well transhumanism as a field of academic study.6 
                                                 
1  Betty Friedan, The Feminine Mystique (New York: W.W. Norton, 2001), 57. 
2  Ibid., 57-58. 
3  James Hughes, Citizen Cyborg: Why Democratic Societies Must Respond to the Redesigned Humans of the 
Future (Cambridge, MA: Westview, 2004), 165-169. 
4  For instance, Max O’Connor became Max More, Tom Bell became T.O. Morrow, Nancie Clark became 
Natasha Vita-More, and Fereidoun M. Esfandiary became FM-2030. 
5  Extropy, in this view, is not a scientific principle per se, but rather a conceptual opposite indicating the 
limitlessness of the human potential for self-transformation and improvement. 
6  http://ieet.org/index.php/IEET/purpose.  
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The Extropy Institute closed in 2006, and its founders took over many of the senior 
positions at the World Transhumanist Association, which was then rebranded as Humanity Plus 
to signal the optimism and ideology of the movement. The democratic transhumanists then 
founded the Institute for Ethics in Emerging Technologies. These technoprogressives more 
readily acknowledge some of the serious risks associated with transhuman projects but still 
believe that a directed evolution of humanity to increase intelligence, longevity, etc. is the best 
choice for the future of humanity and the planet. 
There are other sub-movements within transhumanism as well, the most well-known and 
influential of these being Singularitarianism. Historically, the idea of the Singularity referred to 
the center of a black hole – infinite density at zero volume, from which nothing can escape. In 
1993, science fiction author Vernor Vinge used the term to refer to the rapidly approaching point 
in human history at which the rate of technological change becomes so rapid that past it lies an 
unpredictable qualitative shift in the nature of the experienced universe.7 Singularitarians form a 
quasi-millenarian movement in their expectations for the shape of technological and cultural 
change in the next few decades.  
They base their predictions on extrapolations from Moore’s Law, which states that the 
availability of computing power for the same price is doubling every 18-24 months.8 Based on 
the exponential increase of this processing power, human-created technologies will quickly 
match, and then surpass, the processing power of the human brain, thus creating a self-improving 
superintelligence.9 Once this superintelligence exists, there is no way to further predict what the 
future will hold. Humanity may, and would likely be, annihilated in such a scenario, or we may 
be merged into the universal consciousness of the superintelligence. While it may seem that 
Singularitarians might be marginalized, they have actually become quite politically powerful, 
especially among high-tech companies and university programs. They are well-organized, 
running both the Singularity Institute for Artificial Intelligence, which is a think tank and 
advocacy organization, and the Singularity University as an educational group that is co-
sponsored by companies like Google, Nokia, and Cisco.10  
Transhumanism as a broader movement is opposed in ideology and practice by a diverse 
group of bioconservatives, ranging from environmentalists and some feminists of the left to 
religious and cultural conservatives on the right. My own position is one that seeks the middle 
ground transhumanist technoutopians and their bioconservative detractors. This position, which I 
call technorealism, will be outlined in its beginnings at the conclusion of this paper. 
I find the democratic, or technoprogressive, sub-movement of transhumanism to be the 
most ethically and politically promising of the various groups of transhumanists, and thus the 
remainder of this paper will specifically address democratic transhumanism in relation to a 
                                                 
7  Vernor Vinge, “The Coming Technological Singularity: How to Survive in the Post-Human Era,” NASA 
VISION-21 Symposium presentation, March 1993. 
8  Ray Kurzweil, The Singularity is Near: When Humans Transcend Biology (New York: Penguin, 2005), 41. 
9  Ibid., 10, 14ff. 
10  Singularity Institute for Artificial Intelligence, www.singularity.org. Singularity University, 
www.singularityu.org.  
5 
broadly liberal and democratic global feminism. I will first discuss points of general agreement 
between these transhumanists and feminists, followed by some points on which I believe that 
feminists can provide a necessary corrective to some of the more problematic aspects of 
democratic transhumanism. 
The first point of strong agreement would be the importance of democratic governmental 
and social structures. Many feminists have rightly critiqued various aspects of liberal democracy 
and most would not see it as the panacea envisioned by democratic transhumanists.11 The 
narrative of “better living through science and democracy” is one that has inspired skepticism 
among feminists who question the power relations involved, whose interests are secured and 
whose interests obscured in the master narrative.12 But these groups can still certainly agree that 
a self-governing, nonauthoritarian body politic is the best form of government that human beings 
have devised.  
We also generally agree on the need to have serious considerations of the global justice 
impacts of policy choices, including the need for a political and economic structure that provides 
for the basic needs of all persons. Inequality has risen substantially alongside the development of 
advanced healthcare, genetic, and information technologies, and while the one is not a direct 
function of the other, the particular political policies with regard to technology that have been in 
place have exacerbated, rather than alleviated, that inequality.13 Some democratic transhumanists 
have tended to be defensive when questions of global justice arise, assuming that anyone asking 
the questions has a secret goal of banning all new technologies and creating equality through a 
race to the bottom.14 That need not be the case, though, and liberal feminists and democratic 
transhumanists can work together to ensure that more just social, economic, and political 
structures accompany the development of emerging technologies. 
Feminists and democratic transhumanists likewise share the value of universal 
flourishing, or in the parlance of the Transhumanist Declaration, “the well-being of all 
sentience.”15 The opportunity to live a life in which one has general freedom of self-
determination and a lack of unnecessary suffering is a vision toward which we should strive. 
Feminists and other liberation-oriented scholars and activists have long sought to expand the 
circle of who counts in the moral community, who is understood as a person, and whose values 
and interests are worth protecting. I believe that there has been real moral progress made in 
recent centuries in the expansion of the moral community, coming to include first those outside 
of the tribe, then outside the nobility, those without property, women, persons of African 
                                                 
11  Key examples include the works of Alison Jaggar, Feminist Politics and Human Nature (Lanham, MD: 
Rowman & Littlefield, 1983) and Catharine MacKinnon, Toward a Feminist Theory of the State (Cambridge, 
MA: Harvard University Press, 1989). 
12  Hughes (2004), 3. 
13  Florence Jaumotte, et al., “Rising Income Inequality: Technology, or Trade and Financial Globalization?” IMF 
Working Paper, July 2008, http://www.imf.org/external/pubs/ft/wp/2008/wp08185.pdf.  
14  Author conversation with James Hughes, Emory University, Second Annual Neuroethics Symposium, 
“Neurocognitive Enhancement: Its Impact on Human Mind and Evolution,” May 2, 2011. 
15  Humanity Plus, “Transhumanist Declaration,” http://humanityplus.org/philosophy/transhumanist-declaration/.  
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descent, persons with disabilities, queer folks, and so on. This expansion has come through hard-
fought moral and political struggles and continues now. 
This well-being is tied strongly to both individual and social freedom, and democratic 
transhumanists and liberal feminists have sought a socioeconomic system in which a social 
safety net exists to guarantee the greatest possible freedom for individuals to pursue their well-
being.16 Feminists have been advocates for important rights to bodily integrity in work, family 
and marital life, reproduction, and legal structures. Democratic transhumanists likewise seek 
rights of bodily integrity that pick up on some of the strains of classic feminism and take them in 
a new direction toward the availability of technological interventions in the body. 
Democratic transhumanists, in their better moments, are not unequivocal advocates of 
any and all technological developments that people may want, but choose to apply critical ethical 
analysis to particular technologies and applications and to support or not support them 
accordingly. While generally advocating the maximum possible individual freedom that is 
consistent with similar freedoms for all others, democratic transhumanists understand that there 
are some applications that detract from freedom, exacerbate inequality, and fail to promote well-
being.17 Feminist technology thinkers have tended to promote a middle-ground position that 
takes seriously both the risks and benefits of new technologies and underscores the importance of 
ethical analysis at every stage of development and implementation of new technologies.18 
While there are a number of shared values and practices between liberal feminism and 
democratic transhumanism, there are also some aspects of transhumanism that feminists have 
seen as in need of critique. Some of these are disagreements of emphasis or policy priority, 
others take a slightly different point along a broader spectrum, and others question some of the 
master narratives and assumptions behind transhumanism in general. 
Feminists take a wide variety of perspectives with regard to the nature of moral 
personhood, whether personhood is based in relationality, particular moral or intellectual 
capacities, or some other set of qualities. James Hughes argues for a definition of person 
stemming from John Locke: as “a thinking, intelligent being, that has reason and reflection.”19 
While no one would argue that rationality is a bad thing to possess, there has been a longstanding 
set of criticisms arising from within feminist thought to reject an equation of personhood solely 
with the mind or rationalism.20 This critical perspective is taken for two primary reasons:  first, 
feminists have shown the importance of the particularities of embodiment and physicality in both 
                                                 
16  For instance, in Justice, Gender, and the Family, Susan Moller Okin picks up on Rawls’ understanding of 
political fairness in a liberal society and expands it, arguing that families also need to be just institutions in 
order for the broader society (including the state) to be just. 
17  This understanding of justice is largely based on the social contractarian work of John Rawls in A Theory of 
Justice (Cambridge, MA: Belknap, 1999), particularly the first principle: “each person is to have an equal right 
to the most extensive scheme of basic liberties compatible with a similar scheme of liberties for others.” (53) 
18  A key text that helped to birth the field of feminist technology studies is Donna Haraway’s “Cyborg 
Manifesto,” in Simians, Cyborgs, and Women (New York: Routledge, 1991). 
19  James Hughes, Citizen Cyborg, (Cambridge, MA: Westview), 2004, 81. 
20  Susan Bordo, The Flight to Objectivity: Essays on Cartesianism and Culture (Albany: State University of New 
York Press, 1987), 2ff., Vicki Kirby, Telling Flesh: The Substance of the Corporeal (New York: Routledge, 
1997), 129ff. 
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personal and political identity. I do not simply have a body; in a very real sense, I am a body, and 
reducing personhood to intellectual capacities ignores the very ground from which rationality 
arises. Second, feminists have been critical of philosophical and political moves to reduce moral 
personhood to rationalism because of how the notion of reason has historically been used to 
exclude women, Africans, person with disabilities, and others from full moral and political 
standing.21 The exclusion has been made on the grounds that some humans do not possess the 
right kind of rationality, or enough of it, to satisfy the definition given by those men with enough 
power to enforce it. 
Hughes makes the claim that “persons don’t have to be human, and not all humans are 
persons.”22 I would agree with one side of that claim but not the other. Old fashioned human 
rights need to continue to be guaranteed so that we do not find ourselves as a society slipping 
back into exclusionism amidst possible technologies that may make some persons even more 
“rational” or intelligent than others. But the moral community can and should continue to be 
expanded. While I believe that all humans should be counted as persons, this does not mean that 
robots, genetically engineered monkeys, and various kinds of posthumans could not be persons 
as well. 
Transhumanists, including democratic transhumanists, have shown a rightful skepticism 
regarding the role of government coercion in the adoption or non-adoption of emerging 
technologies. No one should be legally required to incorporate particular technologies into her 
body, and with some basic protections for public and personal safety, should generally not be 
restricted from doing so either. But transhumanists tend to discount other forms of extralegal 
coercion that can have just the same impact through economic or cultural means. For instance, 
there is broad agreement between feminists and transhumanists that one should not be required 
by law to receive a direct brain-computer interface if one does not desire it. But imagine that I 
want a job as a network engineer – should the company hiring me be allowed to require that 
interface as a condition of employment? Should I be required to have certain “upgrades” in order 
to attend a particular school, or to receive health insurance? Coercion must be taken seriously as 
more than a simple matter of governmental intrusion or non-intrusion, and simply saying that 
people can opt-out is insufficient. People need health insurance, education, and employment, and 
the rights of humans 1.0 need to be protected in a broader scope. 
Feminists also question the master narrative of scientific progress that is almost universal 
within transhumanism. In this narrative, “reason, science, and technology…(are) slowly freeing 
us from ignorance, toil, pain, and disease.”23 Philippe Verdoux, himself a transhumanist, has 
recently analyzed this tendency among a variety of transhumanists, including Nick Bostrom, 
Max More, and Ray Kurzweil, and has sought to rid transhumanism from this discredited 
Enlightenment narrative. Verdoux argues that “the progressionist conception of history as ‘a 
record of improvement in the conditions of human life’ is highly problematic, both empirically 
                                                 
21  Katie G. Cannon, Black Womanist Ethics (Atlanta: Scholars Press, 1988), 7. 
22  Hughes (2004), 79. 
23  Hughes (2004), 3. 
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and methodologically…(while) most transhumanists today accept progress as a ‘central dogma’ 
of their technocentric worldviews.”24  
Things don’t get better simply because we have the latest and greatest technology. While 
I would certainly argue that there is such a thing as genuine progress, such as universal literacy 
or peaceful and free societies, these are not guaranteed either by the trajectories of history or the 
development of technology. Technologies can be used to support both freedom and tyranny. 
Technology is not inherently either the problem or the solution, but is instead a tool through 
which ethical progress might be implemented or hindered. 
The narrative of progress through reason and technology comes out of an Enlightenment 
rationalism, and this tends to become combined with a necessarily secular, even virulently anti-
religious perspective. While not all transhumanists are anti-religious, they place a quasi-religious 
faith in “technological optimism” and human capacities for technological self-improvement to 
“become like gods.”25 A survey of transhumanist literature reveals an antipathy within the 
movement to any sort of theism, supernaturalism, ecological spirituality, or anything associated 
with “traditional” religions.26 William Sims Bainbridge reads transhumanist technological self-
transformation as a “positive feedback loop that…may put conventional religion out of business” 
by assuming that the key function of religion is the imposition of taboos by religious authorities 
in order to suppress human potential, uphold an existing religious hierarchy, and mark any 
attempt at self-mastery through technology as an idolatrous violation.27 But even his pilot study 
contradicts this claim that religion is inherently conservative and anti-technology. Even among 
an oversampling of highly conservative religious persons, Bainbridge’s study found that large 
numbers of those who put great confidence in organized religion supported having all of one’s 
experiences recorded as a form of self-preservation and the injection of nanites into the 
bloodstream for increased longevity in medical care. Many of the differences between the very 
religious and the non-religious were small, though his report selects the most stark examples of 
sweeping anti-technology statements by religious persons and ignores the large areas of overlap 
between the groups.28 This obsessive anti-religious sentiment is both politically unhelpful and 
ethically problematic, as it leads to mischaracterization and condemnation of those with whom 
one disagrees. 
Liberal feminism has provided stark criticisms of various forms and practices of religion, 
particularly the instantiations of patriarchy and misogyny they often uphold by giving anti-
woman positions a divine sanction. And certainly, some feminists do hold anti-religious 
                                                 
24  Philippe Verdoux, “Transhumanism, Progress, and the Future,” Journal of Evolution and Technology 20:2, 
2009, 50. 
25  William Sims Bainbridge, “The Transhuman Heresy,” Journal of Evolution and Technology, 14:2, 2005, 91. 
26  For instance, a recent survey by the IEET found that over 70% of its readership was agnostic or atheist 
(http://ieet.org/index.php/IEET/more/religionpollresults20120602), and they have begun to publish articles on 
why transhumanists could be more successful if they spent less time “bashing religion,” in response to the 
routine comments and articles that have issued from the transhumanist community. (George Dvorsky, “Why 
Humanists Need to Make the Shift to Post-Atheism,” IEET blog: 
http://ieet.org/index.php/IEET/more/dvorsky20120515, May 15, 2012). 
27  Bainbridge (2005), 91, 92. 
28  Ibid., 96-97. 
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positions. But within feminism, space has been made for religious feminists, including feminist 
theologians and activists. A diverse group of feminist religious groups has developed, doing 
work in political advocacy, among religious denominations and organizations, and in parachurch 
and other faith-based organizations. And these are not co-opted by anti-religious feminists for 
other purposes; they live side by side, working together where they can and separately where 
they disagree. The same cannot be said of transhumanism, where a pervasive anti-religiosity 
holds sway, and religious practitioners as an undifferentiated group are regularly denigrated in 
presentations, printed works, and websites. 
Democratic and other transhumanists endorse public policy initiatives that heavily fund 
the development of technologies they see as enhancing, including extreme longevity 
technologies, germline genetic interventions, and friendly artificial intelligences. They argue that 
existing social problems, such as massive wealth inequality, are not a reason to halt technological 
innovation, and on this they are correct. But there is reason to be skeptical of the absolute 
urgency claimed for the sexy high tech and the utter demonization of anyone who opposes 
particular technological developments or finds that perhaps more funding should be given to 
alleviate the crushing problems of a lack of clean water, housing, food, and healthcare currently 
faced by many in the world. Surely we can both provide enough food for all while developing 
nifty humanoid robots, great cancer treatments, and the like. But we humans are not very good at 
feeling the urgency for too many policy priorities at once – some things are emphasized while 
others are de-emphasized, and I want to ensure that in the rush to develop the new and the cool 
the problems of today are not forgotten. I appreciate the efforts of democratic transhumanists to 
support initiatives like universal healthcare and hope that those efforts can form a common 
ground for action. 
Feminist and disability studies scholars also question some of the easy assumptions made 
by transhumanists regarding what constitutes “enhancement” and why. On the one hand, 
transhumanists support a variety of individual choices with regard to enhancement and lifestyle, 
and individual freedom and bodily integrity are core feminist values. On the other hand, there are 
subtle and not-so-subtle ways in which contemporary transhumanists assert their own values and 
preferences in talking about enhancement, personhood, and the future of society. There is 
generally an assumption made that, while existing persons with disabilities should not be 
discriminated against, it would be better in the long run for society if only non-disabled persons 
were born.29 This assumes a fairly objective, medicalized model of disability in which 
disabilities are stable, identifiable, and in need of medical treatment, rather than a contextualized 
and socio-political one in which understandings of disability are heavily influenced by the way a 
particular society is constructed.  
The debate regarding the choices of deaf parents to choose to bear deaf children is 
instructive here. Deaf activists argue that deafness is a culture, rather than a disability, and that 
deaf people lead full and free lives within that culture, so parents should be free to intentionally 
                                                 
29  Hughes (2004). 238. 
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bear children whom they can raise to be full participants within that culture.30 Transhumanists 
like Hughes, however, see that choice as one of invariable deprivation and harm to the child.31 
They implicitly assume that their own able-bodiedness and intelligence are to be valued and 
discount or disregard the values gained by other ways of being.  
The impacts of the differences between liberal feminist reflections and those of 
transhumanists can be understood through the lens of debates over technology developments in 
healthcare. The major healthcare developments of the coming years will likely be something of a 
continuation of recent trends toward the technologization of medicine, including robotic surgery, 
personalized medicine, genetic interventions, life extension, and the integration of technology 
into human bodies as part of routine medical care. 
Just as the dramatic changes in medical technologies affected the practice of medicine in 
the 20th century, so further changes will continue to impact medical practice in the 21st century. 
This is particularly true in the case of the NBIC technologies – nanotechnology, biotechnology, 
information technology, and cognitive science. While historically these have functioned quite 
separately and, in some cases, have had little to do with the practice of medicine, they are 
increasingly convergent technologies. Nanoscale particles are being developed as targeted 
medicines, powerful computer databases are able to aggregate huge amounts of data to provide 
insight into genomics, long-term research projects, and clinical decision-making. Cognitive 
science developments in concert with advanced information technologies are providing greater 
understanding of the functions of the brain along with the increasing ability to modify those 
functions. Humanoid robots are being developed with applications in several areas of medicine – 
from nurse-bots to lift, turn, and provide medicines to those in need of 24-hour care to robotic 
arms in precision surgery to artificial intelligence systems that can accurately diagnose and 
provide treatment for a wide range of illnesses, the practice of medicine is continuing to change 
and healthcare providers may become the next set of workers to have their jobs automated and 
largely replaced by machines. 
I believe that issues of justice are paramount in the availability of healthcare, including 
advanced healthcare technologies, and even more so in the case in which “enhancement” 
medicine is likely to further increase the disparities between rich and poor. Currently in the 
United States, the most medically technologized nation in the world and the only industrialized 
nation not to provide health insurance to all of its citizens, over 22% of adults under 65% have 
no health insurance whatsoever32, and many more are underinsured such that a major illness 
would have financially catastrophic consequences. “Medical problems caused 62% of all 
personal bankruptcies filed in the U.S. in 2007... [Yet] 78% of those filers had medical insurance 
                                                 
30  H-Dirksen L. Bauman, “Designing Deaf Babies and the Question of Disability,” Journal of Deaf Studies and 
Deaf Education 10.3, Summer 2005. 
31  Hughes (2004), 13-18, 238. 
32  CDC, “Fast Stats: Health Insurance Coverage,” November 17, 2011, 
http://www.cdc.gov/nchs/fastats/hinsure.htm.  
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at the start of their illness.”33 Over the past 30 years, the real (constant dollar) income of the 
bottom 90% of Americans has shrunk, even while technology and health care costs have risen 
dramatically.34 Likewise, though there have been real gains in the opportunities for some people 
that have been brought about by the development of internet and related technologies, 
technology has not solved many major social issues. The disparities are even starker when 
considered in a broader global context. Globally, approximately one in eight people lack access 
to safe water, and “more people in the world have cell phones than access to a toilet.”35 One in 
seven people on earth have insufficient food,36 and just as many lack any access to healthcare.37 
It is not for lack of technology that these problems continue, but for lack of political will. 
Many advancements in medical technology, including sterile surgery, antibiotics, 
vaccines, birth control, and the like, contributed to a dramatic increase in life expectancy in 
developed nations during the 20th century. Scientific and technological advancements were 
critical to increases in health and longevity on a global scale, but technology alone does not solve 
global crises. As with all new technologies, emerging medical technologies are first available 
only to the very wealthy and then eventually are common enough to be covered by insurance and 
affordable for people in developed nations. But many of these technologies do not “trickle-
down” to the point of being affordable to the world’s poorest, or even the less well-off in nations 
like the US. It takes significant and intentional choices in political, economic, and social policies 
in order to make good healthcare broadly accessible.  
For instance, AZT and others AIDS medications were initially terribly expensive and 
unavailable to most people suffering from the disease. After they had been introduced and 
political pressure in the US strongly encouraged the company making the drug to lower their 
prices, AZT began to be covered by more Americans’ medical insurances. But AZT only became 
available to the world’s poor because of massive political pressure on GlaxoSmithKline to lower 
their prices prior to the drug’s patent expiring in 2005. Here the technology was a necessary, but 
not sufficient, condition for the possibility of solving the global AIDS crisis. It also takes 
political will, public pressure, an effective global distribution system, and a strong healthcare 
infrastructure to provide the care needed by so many. 
Effective and inexpensive treatments for a wide range of other conditions, such as 
malaria, remain underfunded in both development and distribution, so there remain 
approximately 225 million cases of malaria annually worldwide.38 Public pressure here has 
resulted in substantial increase in funding for insecticide-treated mosquito nets and antimalarial 
                                                 
33  Catherine Arnst, “Study Links Medical Costs and Personal Bankruptcy,” Bloomberg Businessweek, June 4, 
2009, http://www.businessweek.com/bwdaily/dnflash/content/jun2009/db2009064_666715.htm.  
34  http://motherjones.com/politics/2011/02/income-inequality-in-america-chart-graph 
35  Water.org homepage. 
36  UN World Food Programme, “Hunger Stats,” http://www.wfp.org/hunger/stats.  
37  Arnup Shah, “Health Issues,” http://www.globalissues.org/issue/587/health-issues . 
38  WHO World Malaria Report 2010, 
http://www.who.int/malaria/world_malaria_report_2010/malaria2010_summary_keypoints_en.pdf.  
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medications, but these are available at levels well below what is needed in order to fully and 
effectively combat malaria.39  
In the example of malaria, technologies such as insecticidal netting and antimalarial 
medications have been developed and are part of the solution, but there also must be public 
pressure for the political decision to make the eradication of malaria a priority on a global basis. 
Once this policy goal has been established over time and pubic leaders held accountable for 
upholding it and funding it as a priority, then there must be the necessary technological 
development to create the conditions of possibility for an effective solution. Substantial public 
and private money must be spent wisely to develop the technology, but even the development of 
the right technology is not the end. There then have to be fair and just structures through which 
to distribute the technology, such as a new generation of antimalarial medications.  
Malaria is something of a different case here because there is not substantial public need 
for antimalarial medications in the developed world to compete with the needs of the developing 
world. There remains, however, the need for access to effective treatments by a broad range of 
persons throughout the world as well as the infrastructure to produce and deliver those 
medicines. Each step, from the decision to make a particular challenge a political priority, to the 
choice to fund the research and development needed to develop the technology necessary to 
create the possibility of a solution, to the political choice needed to ensure that the technologies 
that are developed do not simply benefit the already well-off, the problems are rarely primarily 
technological in nature. Technology is part of the solution, but if delivered unjustly, can also 
become part of the problem by exacerbating existing inequalities. 
To take another, more currently theoretical case, let’s say that a new nanoscale drug was 
developed that allowed otherwise relatively healthy people to extend their healthy lifespans so 
that the person taking the drug could reasonably expect to live to 120. Such a drug would be 
hugely expensive to develop, so the first question is whether such a drug should be sought 
through publicly funded research. Once a choice has been made to actively fund the development 
of such a drug, it would be very costly to conduct the necessary research and development to 
have the drug meet FDA approval. So here the initial political decision has been made to conduct 
funded research – to make life extension treatments a public priority, which generally means the 
choice not to fund some other area of research. Certainly a policy decision could be made to allot 
a much greater sum to medical research in general, but this would also require much greater 
infrastructure in education, facilities, and equipment for years before becoming a viable option. 
Given current infrastructure and funding levels, the decision to develop life extension 
technologies would require the defunding of some other policy priority – and public pressure 
would help to determine what that would be.  
Once the decision has been made and funding given over the extended period of time 
necessary for development and clinical trials, only then do questions of distribution and access 
arise. Our life extension drug would have the potential to be useful to anyone in the world and 
                                                 
39  Bill and Melinda Gates Foundation, “Malaria: Strategy Overview,” April 2011, 
http://www.gatesfoundation.org/malaria/Documents/malaria-strategy.pdf.  
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would have universal demand accordingly. Certainly the drug would initially be available only to 
those who could afford its marked up retail cost – it would almost certainly not be covered under 
insurance, as it does not treat a specific and broadly recognized disease – so as a cosmetic or 
voluntary treatment payment for the drug would be entirely private. It is possible that such a 
treatment might eventually be covered by some of the better health plans in the US, not unlike a 
procedure like IVF today. It would take a long time for this drug to be accessible under a 
national health plan in those nations that have one, and given the universal market demand, 
would likely not ever be made readily accessible to the majority of the world’s population. 
Unlike AZT or antimalarial medications, the target market is not people in the developing world, 
so it would be surprising if it were ever made affordable to them. Like IVF, it would remain the 
province of the wealthy and would have the potential to increase existing disparities in healthy 
life span that exist today. 
Transhumanists want to push forward and claim that life extension technologies are 
among the most pressing research priorities today – after all, everyone could benefit from a 
longer, healthier life. Bioconservatives, on the other hand, generally do not believe that such 
drugs should be prioritized or developed, whether through choosing never to publicly fund 
transhuman technologies or through public prohibitions on that development. But I do not think 
that the best approach is to ban the development of our life extension drug, but to regulate it and 
ensure that it does not overtake other urgent public health priorities, and to make broad 
distribution possible through creative intellectual property applications so that it did not increase 
health disparities. 
I hope to forge a middle ground between transhumanists and bioconservatives. It might 
be called the enhancement conversation 2.0. Until recently, discussions of human enhancement 
through technology have tended to be sharply divided into two opposing camps, supporters and 
detractors, who talk past one another, give ungenerous readings of one another’s positions and 
arguments, and generally park themselves firmly in their own camps, resisting criticism or 
moderation. I believe that a critical feminist perspective as outlined here can provide something 
of a roadmap for the ground between the extremes – a feminist technorealism. This 
technorealism moves beyond “us vs. them” and the current biopolitics of personal destruction. It 
balances the optimism that we can make choices that have positive impacts in the world around 
us with the skepticism that we, humans 1.0, tend toward selfishness, rationalization of our own 
choices, and a lack of empathy for those we do not know, suffering far away from our sight. We 
can choose a position between an extreme version of the precautionary principle, in which no 
technology can be developed until all of its possible effects are known, and a proactionary 
principle in which technology development can and must move full speed ahead.40 Constructive 
discussions around risk and benefit need to happen on a global basis, not just among those who 
currently enjoy the advantages of technology and would benefit most from further development. 
                                                 
40  For a good variety of working definitions of the precautionary principle, see the UNESCO World Commission 
on the Ethics of Scientific Knowledge and Technology (COMEST) report, “The Precautionary Principle,” 
(Paris: UNESCO, 2005). The Extropy Institute published a working definition of the proactionary principle that 
highlights its contrasts with the precautionary principle: http://www.extropy.org/proactionaryprinciple.htm.  
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These discussions would not look at transhuman technologies as an all-or-nothing proposition 
but would take seriously how and why particular technologies are developed, the uses to which 
they are put, and the social, economic, and political systems in which they are developed and 
made available. Finally, a feminist technorealism acknowledges that technology, in and of itself, 
does not make life better, freer, or happier. Advanced technologies only provide some means to 
the end and tend to amplify the effects of our choices. Technology and democracy can provide 
the conditions of the possibility of a better world, but there far more that we collectively need to 
choose each day to reach it. 
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Abstract 
This paper reports results from an empirical study of the effects of incidental findings on 
research subjects who took part in a whole-body MRI examination within a larger population-
based study in Germany. Following a brief review of the background and methods for this 
study, important quantitative and qualitative results will be discussed. The findings of this 
study suggest that a) inordinate or disproportionate stress is not observed in the vast majority 
of research subjects receiving incidental findings, despite assumptions to the contrary. 
However, an important caveat from the point of view of research ethics is that b) reactive 
stress, where it does occur, can be reduced by various measures, e.g. by modification of the 
approach to reporting findings and that c) approaches to informing research subjects of 
incidental findings from this type of study should be improved so that the research subjects 
can evaluate the validity of whole-body MRI results more realistically. 
 
Keywords: Incidental findings, Whole body MRI, Population based medical research, 
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research ethics  
Background 
A team at the chair of Systematic Theology at the Faculty of Theology at the Ernst-Moritz-
Arndt-University of Greifswald has served as integral part of a project named GANI_MED 
(Greifswald Approach to Individualized Medicine) since October 2009, with Prof. Dr. 
Heinrich Assel serving as the head of the collaborating team. The overarching aim of 
GANI_MED is to establish a program in predictive Individualized Medicine at the university 
hospital. “Individualized Medicine” is taken in this project to be a combination of approaches 
and methods intended to improve medical prediction. These approaches would involve the 
integration of a range of clinically relevant parameters into clinical care in order to predict 
individuals’ risk for developing certain diseases or to predict the future course of pre-existing 
conditions. Moreover, these approaches would ideally predict the success of therapies with a 
high degree of specificity and sensitivity.2 
The team at the chair of Systematic Theology has addressed a number of research 
ethics questions within GANI_MED, with a focus on two sub-projects: 
1. The first sub-project aims at assuring that within GANI_MED the informed consent (IC) 
process and all related processes  (data storage, data usage, biobanking etc.) are carried out 
according to legal and data protection standards, as well as standards of research ethics. This 
also includes creating the documents and informational pamphlets that are utilized in the IC 
process, cooperation on the design of data protection approaches and biobanks, current 
training for staff involved in patient information, and the development and implementation of 
recommendations regarding the practical arrangement of ethically sensitive processes within 
GANI_MED. 
2. The other sub-project uses the methods of empirical social science in order to examine the 
effects of reporting incidental findings3 on participants in medical research, with the SHIP  
study (Study of Health in Pomerania)4 serving as the primary example. SHIP is a population-
based study also established at Greifswald University. This manuscript focuses on the special 
issues pertinent to whole-body MRI performed as a part of this study. 
The SHIP study was examined as a case study to help identify the issues relevant to returning 
incidental findings that could arise in GANI_MED. MRI examinations were planned for 
specific GANI_MED cohorts outside of clinical routine. Therefore, it was quite clear that the 
                                                 
2  For aims, concept and structure of GANI_MED cf. Langanke et al. Gesundheitsökonomische Forschung, 
pp. 105-121 and Langanke et al. Different Approaches, pp. 440-441. The term of biomarker relevant for 
GANI_MED is explained in Langanke/Fischer. Gesundheitsmanagement, pp. 142-143. For the general 
debate about Individualized or Personalized Medicine cf. Golubnitschja, Predictive Diagnostics and 
Niederlag et al. Personalisierte Medizin. A very good overview of the different varieties and approaches is 
provided in Hüsing et al. Individualisierte Medizin. 
3  A very good introduction to the current international discussion about incidental findings within non-
clinical research is given by Hoffmann/Schmücker, Ethische Problematik. Furthermore, they adjust the 
term “incidental finding” as the presented paper does: An incidental finding is a non-intended finding 
which is the result of a study with research subjects and has an effect on the health or reproduction of the 
people concerned. Cf. Hoffmann/Schmücker. Ethische Problematik, p. 3. 
4  For the cohort profile within SHIP cf. Völzke et al. Cohort Profile. 
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risk of incidental findings and – connected with this – questions about the appropriate 
methods for reporting these incidental findings would be raised in GANI_MED. The purpose 
of carrying out an empirical study of the MRI component of the SHIP study was to identify 
best practices relevant to the protection of research subjects and to guide quality 
improvement efforts as a part of GANI_MED. The SHIP whole-body MRI was a natural 
object of investigation because a) it served as a case study and reference for GANI_MED in 
discussions with the research ethics committee regarding the design of research processes, 
and b) it generated a relatively large number of incidental findings. 
Method and Design 
The study was primarily exploratory in nature, since there were almost no publications 
available about the effect of reporting incidental findings from whole-body MRI studies to 
research subjects. For this reason, no previously validated instruments were available relevant 
to this set of research questions.5 The exploratory character of this study is underlined by the 
order and choice of methods, especially its two-stage mixed-methods study design: For the 
first stage (quantitative) it was important to identify whether certain pre-empirical 
assumptions about expected stress are correct; thus we examined whether and to what extent 
certain prima facie expected stresses would arise. In the second stage (qualitative) we sought 
to clarify the details for those findings in the quantitative part that were unexpected or 
seemed counterintuitive, i.e. regarding those results which did not confirm or even refuted the 
pre-empirical expectations. In the course of this study, the advantages of this study’s mixed-
methods design became obvious.6 
The quantitative portion of this study was based on two questionnaires while the 
qualitative portion was based on an interview. The first questionnaire was administered to all 
SHIP research subjects who underwent whole-body MRI in the period between March 3, 
2010 and July 23, 2010. The questionnaire was administered to them in the period between 
the MRI examination and the following final consultation (n = 439, response rate = 96.5 %). 
The second questionnaire was mailed to participants. This timing for mailing the 
questionnaire was based on an algorithm that included, among other factors, whether the 
participant had received an incidental finding and, for those who did, whether four weeks had 
elapsed since that notification, in order to give them time to pursue further evaluation to 
clarify the finding. In total, the response was very high for the second questionnaire, as well 
(n = 409, response rate = 93.2 %). These values are especially striking given that this 
questionnaire was administered by mail! 
At the beginning of the study the frequency of incidental findings was anticipated to 
be 30%.7In actuality, 152 out of 439 research subjects (34.6 %) received one. 134 of these 
                                                 
5  A survey by phone had previously been conducted in the summer of 2009. In this study, 20 research 
subjects who had participated in the whole-body MRI examination and received a report of incidental 
findings, were interviewed. This was the pilot phase for the development of a questionnaire designed by an 
interdisciplinary team (representatives of epidemiology, psychology, psychiatry, radiology and ethics). Cf. 
Schmidt et al. Psychosocial consequences. 
6  For the advantages of integration of quantitative and qualitative methods cf. Kelle. Integration, pp. 227ff. 
7  The number of incidental findings detected with imaging methods always depends, naturally, on the study 
protocol used for the examination, i.e. which body part is examined with which method. Wolf et al. 
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152 research subjects responded to the postal questionnaire. Four research subjects out of this 
group reported that they did not receive a written report of findings. However, one of them 
answered the relevant questions, though incomplete. It is not clear why another four research 
subjects, who said that they got a report of findings, did not answer the questions within the 
relevant section despite the fact that they completed the rest of the questionnaire. Overall, in 
the following analysis we will refer to these 131 questionnaires when speaking of the group 
“with incidental findings”. 
14 research subjects said, surprisingly, that they received a report about a finding 
despite the fact that this was not the case according to the staff responsible for mailing the 
written reports within SHIP. Perhaps these statements by the research subjects referred to the 
final consultation or the oral report of a finding at the end of the MRI examination. The 
answers of these particular questionnaires were not used for the analysis because they could 
not be connected to any written report of findings. 
Interviews were scheduled with 24 research subjects. These participants were chosen 
based on their answers to questionnaire items. For instance, some were selected because they 
reported high stress or dissatisfaction, or because at least one response in the second 
questionnaire differed significantly from their response to that same item in the first 
questionnaire. The first three interviews (B1 – B3) were needed in order to improve the 
approach and discussion guide, and were thus not used in the analysis. In addition, interview 
B17 could not be used because it was not properly recorded. In total, 20 interviews were 
analyzed. Every interview was divided into two parts: the first part was conducted 
methodologically as a narrative interview8, i.e. the person was asked an initial question9 in 
which he or she was asked to tell everything that came into mind regarding the whole-body 
MRI examination, from the invitation to participate up to the report of findings. The second 
portion of the interview was semi-structured. This portion of the interview followed a 
discussion guide designed not to influence the course of conversation too much while 
assuring that all relevant areas were addressed in the interview.10 
The questionnaires were analyzed using SPSS (PASW Statistics 18), while the 
interviews were analyzed with the assistance of the software MAXQDA (10). 
Clarification, diagnostics and report of findings within the SHIP MRI 
study11 
The capability for whole-body MRI has existed since July 2008. First, the head and body are 
examined, taking approximately 70 minutes. Second, additional examinations of the heart and 
the vascular system are performed. For female research subjects, MRI examinations of the 
heart and breast are done.12 
                                                                                                                                                        
Managing Incidental Findings, p. 221 reports that the number of incidental findings in examinations of the 
brain is, for instance, between 13 % and 84 % (sic!). 
8  For narrative interview cf. Flick. Qualitative Sozialforschung, pp. 147ff. 
9  Flick. Qualitative Sozialforschung, p. 147. 
10  For guideline interview cf. Bortz/Döring. Forschungsmethoden, p. 314. 
11  This paragraph follows the presentation by Langanke/Erdmann in MRT als Studienuntersuchung, pp. 202-
209. 
12  cf. SHIP Teilnehmerinformation, p. 10. 
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Before undergoing whole-body MRI, every research subject must first participate in a 
multi-staged program focused on providing information and answering questions. This begins 
with the invitation to participate in SHIP (research subjects are selected at random) when 
each potential participant receives an extensive booklet about the aims and sub-parts of the 
SHIP study.13 Furthermore, persons arriving for an initial visit at the SHIP examination centre 
view a film. This film shows how an MRI takes place and describes the inconveniences 
(claustrophobia etc.) that are associated with participation in this examination. Directly 
before the examination, a personal consultation with medical study staff takes place. In this 
intensive 15-minute consultation the research subjects are informed “about the fact that it is 
possible that unanticipated results will be detected by the MRI which might need further 
clarification”14. On the other hand – according to the interim report – it is also assured that 
research subjects have understood the consequences of the MRI examination in case of a 
positive and/or unclear result which needs further clarification! Moreover, all research 
subjects were informed that the MRI examination is used for study purposes and not 
[highlighting in the original, P.E.] as a screening method.15 
The information is given orally also with the emphasis that some findings, e.g. 
changes with unclear pathological value, will not be reported. If findings that need to be 
reported are detected, the research subjects will be contacted via mail within six to eight 
weeks. 
The report of possible MRI findings within SHIP is performed through a specific 
procedure, of which the steps are shown in figure 1. 
Fig. 1: Reporting of test results within SHIP 
Directly after the MRI, a conversation with the participant takes place during which he or she 
                                                 
13  This is the printed brochure which is referred to as SHIP Teilnehmerinformation here. 
14  Kühn. Ganzkörper-MRT, p. 3. 
15  Ibid. Italic in the original. 
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can be informed about incidental findings which are acute and require immediately therapy. 
These findings are detected in the mode of an ad-hoc diagnosis. After this ad-hoc diagnosis, 
second and third opinions follow. In cases where the results are unclear, e.g. no precedent 
case exists, or differing opinions exist among reviewers, or in case of an apparent neoplasm, 
an interdisciplinary Advisory Board meets. Relevant findings are then forwarded to the 
research subjects in written form.16 
It should be noted that clarification and diagnostics within SHIP are performed 
according to high standards. Great care is taken in both parts of the review process. This is 
demonstrated by an elaborate sequence of sub-processes and by, in case of an incidental 
finding that will be reported, a complex decision tree with various options. The establishment 
of an Advisory Board for the evaluation and processing of new, controversial, or particularly 
difficult cases should be positively highlighted here. 
Results 
This manuscript highlights some of the most important results from this study.17 Results are 
divided into quantitative results (4.1) and qualitative results (4.2), with a short interim 
summary following (4.3). Quantitative results are organized with regard to aspects of 
“stress”, “willingness to participate in future research” and “motivations for participation”. 
Quantitative Portion 
Stress 
During the conception of this study, and again later during the development of empiric 
instruments, negative effects from the MRI examinations and the following report of findings 
were considered. A number of possible stresses were anticipated, including: a) waiting for the 
result, b) the result itself, and c) the consequences which arise from the finding. Given this 
early focus on stresses, responses on the second questionnaire were quite surprising. It 
became clear that the stress introduced by participation in this study was far less than 
estimated beforehand; waiting for the results was described as very stressful by only seven 
research subjects, five said that the waiting was quite stressful, and 21 research subjects 
reported it to be moderately stressful. The majority of the research subjects (91 %) reported 
that they felt little or almost no stress or effect caused by waiting for the result: 
                                                 
16  For detailed information about the diagnostics procedure cf. Langanke/Erdmann. MRT als 
Studienuntersuchung, pp. 240ff. 
17  Due to reasons of space, the results are limited here to the most important ones. The complete analysis of 
the data will soon be provided in a doctoral thesis. 
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Fig. 2: Stress caused by waiting for the test results18 
 
 
If one looks at the stress caused by the report of incidental findings for the 131 
affected research subjects, 71% of them said that they were “not at all” or “a little bit” 
stressed. In contrast, 8.4 % felt “moderately” and 9.2 % “very much” stressed. 
Fig. 3: Emotional stress because of reporting of the test results, n=131 
 
 
                                                 
18  In this and the following figures, the missing values and responses which were recorded incorrectly by 
respondents are not displayed. 
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Having said this, it is clear that overall the stress caused by the report of incidental 
findings is relatively low. Despite this, it should be noted that when it comes to normative 
considerations, an effect in a small number of persons can be quite important.19 For this 
reason, it is important to differentiate the stresses that can be introduced by the report: some 
stress can be attributed to the result itself. This type of stress is inevitable, since unanticipated 
findings that have medical significance must still be reported. However, for certain stressful 
aspects of the report procedure, we must address to what extent that stress can be reduced. It 
should be considered here, for example, the stress that arises because the written report is not 
understood (“a little bit” 19%, “moderately” 8%, and “very much” 2%), or the stress caused 
by waiting for clarification of the finding (“a little bit” 29%, “moderately” 12% and “very 
much” 9%). Consequently, we want to evaluate the stress independent of its degree. In 
particular, we want to evaluate whether or under which conditions it would have been 
preventable, and whether research subjects need to face such stress in the future. 
Retrospective evaluation of participation and willingness to participate again 
Another assumption during the planning of this study was that some research subjects could 
be disappointed considering the discrepancy between the expected and the actual value of the 
MRI examination. Moreover this disappointment, so it was assumed, could have negative 
effects on the willingness to participate again. The questions at the end of the second 
questionnaire were focused on subjects’ satisfaction regarding their participation and their 
willingness to participate again. In this section as well the answers differed from those 
expected. The satisfaction of the research subjects was extraordinarily high as shown in the 
following chart: 
Fig. 4: Satisfaction of the research subjects with the participation MRI examination 
 
Very few participants were unwilling to participate again. The question “If I had been 
provided better information I would not have participated in the MRI examination” was 
answered by 28 research subjects with “yes” (6.8%), 351 research subjects said  “no” 
                                                 
19  For the problem of the “ethical” significance of individual cases of the essentially preventive function of 
norms cf. Langanke/Erdmann. MRT als Studienuntersuchung, p. 221.  
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(85.8 %) and 30 gave no answer or filled it in incorrectly (7.3 %).  
In total, it can be assumed that less than 10 % of the research subjects were significantly 
stressed by waiting for the result and the result itself, whereas “customer satisfaction” and 
willingness to participate again was very high. 
Motivation for participation 
In these responses there was no indication that the study did not meet the expectations of 
research subjects. This can be explained in at least two ways. First, research subjects might 
have had appropriately low expectations for the benefits they would derive from the study. 
Any benefits they did receive, although small, thus met their expectations. On the other hand, 
research subjects might have had high expectations for the benefits they would receive, and 
interpreted any benefits as meeting these high expectations. In light of this, we examined the 
reasons research subjects voluntarily participated in the in the whole-body MRI examination. 
What kinds of expectations with respect to benefit were the most important in their decision 
to participate? Did research subjects realistically assess the risks of the participation? 
Prior to participation in the SHIP whole-body MRI study, research subjects were 
informed of the following benefits: 
 
1) They will be informed about acute life-threatening diseases in a consultation directly 
after the examination. In this case, transfer to the emergency department and/or 
admission to the hospital will be initiated. 
2) Participants will receive a written report if an anomaly is detected which needs further 
examination. This anomaly could possibly be a life-threatening disease and could, if 
this is confirmed, require further therapy and medical supervision. 
3) An explicit exception is that research subjects will not be informed about MRI 
findings related to the spine:  
In the current state of medical knowledge it is not possible to accurately predict pathological 
conditions or complications from MRI findings. Therefore, from our point of view, the 
possible disadvantages which could arise from being informed of any finding definitely 
outweigh the predictive value of such a finding.20 
 
4) Furthermore, research subjects are informed that the “predictive value of the MRI 
examination is still unclear for many diseases”21. Also, the amount and quality of the 
images are chosen for research reasons so that false positive as well as false negative 
findings might occur. 
5) Research subjects are informed that “the MRI examination is done for study purposes 
and not [highlighted in the original, P.E.] as a screening method”22. For the research 
subjects this means that they should continue to attend medical check-ups, despite 
their participation in the whole-body MRI. They should consult a doctor in case of 
unclear conditions which could indicate a serious illness. 
                                                 
20  SHIP Teilnehmerinformation, p. 14. 
21  Ibid. 
22  Kühn. Ganzkörper-MRT, p. 3. 
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When examining the answers on the questionnaires concerning the motivations that led to 
participation, it becomes obvious that not all of the relevant information was understood by 
research subjects: 
Fig. 5: Motivation for participating in the MRI examination 
 
The primary reason given by participants for their decision to take part was the hope 
to find out whether they are healthy (95%). The second most common motivation reported 
was a scientific reason (81%), and the third most common was the chance to clarify certain 
medical conditions (“because I have certain medical conditions and I hope that by the MRI 
examination the reason for that is found”) (39%). At last, 13% thought that by participating in 
the MRI examination they do not have to attend any medical check-ups anymore. In contrast, 
expense allowances seem to play only a minor part.23 
The phenomenon of the Therapeutic Misconception (TM) is detectable in this sample, 
despite the high quality of the IC process adopted within SHIP. This is a common 
phenomenon in medical research studies.24 TM is the general tendency of research subjects in 
medical research studies to have exaggerated or false expectations concerning the personal 
therapeutic benefit of research participation. These expectations occur even if they are 
explicitly denied during IC.25 The participants’ assumption that the SHIP whole-body MRI 
will clarify medical conditions illustrates the phenomenon of TM very well: For the research 
subjects the research interest takes a back seat. Although they take part for scientific reasons 
they want to get something “in return.” According to them, this return is finding out whether 
they are healthy and possibly also finding out the causes for certain medical conditions.26 
                                                 
23  An allowance of 20 € and travel expenses are offered to the test person within SHIP. 
24  cf. Appelbaum et al. Therapeutic Misconceptions, p.1. 
25  This explanation generalizes the definitions suggested for the particular context of clinical studies by 
Appelbaum et al. Therapeutic Misconceptions and Wolf et al. Managing Incidental Findings, with regard to 
managing incidental findings. 
26  The observation that the research subjects participated in the MRI because of something they would get in 
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With regard to issues of research ethics, this observation of TM is alarming. We will 
return to this issue later. But first, another issue raised by responses on questionnaires must be 
raised: Almost all participants think that they will get to know if they are healthy. This is a 
relatively general expectation which is not necessarily problematic. However, if this 
expectation is related to the number of people who think that they no longer need medical 
check-ups because they participated in the whole-body MRI, it becomes very problematic. 
Indeed, only a few research subjects said “yes” when asked if participation in the 
SHIP whole-body MRI would substitute for a medical check-up (in the postal questionnaire, 
52 respondents), in comparison to the 95% who noted approval of the statement “because I 
will get to know if I am healthy”. 23 research subjects out of these 52 received a report of 
incidental findings, in response to which one would expect them to pursue medical treatment. 
However, not all research subjects who received a report did consult a doctor in order to 
clarify the findings that they were told could indicate a serious disease and would need 
confirmation in order to identify a need for further therapy and medical supervision. 29 
research subjects out of this group did not get any finding and will, if they act according to 
their answer in the second questionnaire, no longer attend medical check-ups, or at least 
decrease their attendance.27 
In summary, we can conclude that the stress caused by waiting for the result and the 
stress of receiving a result are not as high as expected. Moreover, research subjects’ 
evaluation concerning their participation in the MRI examination was mainly positive, and 
their willingness to participate again was very high. When placing these positive results in the 
context of other results, we can note that the very positive responses of research subjects can 
be attributed to the fact that they (at least in part) expected a benefit from their participation. 
That participants were pleased with their participation, and must therefore have felt that their 
expectations of therapeutic benefit were met, indicates that a significant misconception was 
taking place. This misconception took place despite the informed consent process, which 
explicitly discounted the therapeutic benefit of the study. And, apparently, research subjects 
encountered no occasion after that consenting process to critically question their expectation 
of benefit from the examination. 
Qualitative Portion 
Before the most important results of the qualitative portion of the study are presented, some 
methodological comments must be made.28 After the publication of initial results29 a 
discussion arose regarding the validity of results of qualitative (social) research in general 
and the representative nature of individual statements by research subjects in particular.30 
                                                                                                                                                        
return is confirmed in the interviews, discussed below. 
27  With this in mind, it is alarming that one research subject stated in an interview that she received a 
notification from “Schwerin” - possibly the central department for mammography screening in 
Mecklenburg-Vorpommern. When she called and talked about her participation in SHIP, “Schwerin” said 
that the MRI examination within SHIP is even better than a mammography and that she did not have to 
come to a screening for the next two years. 
28  A detailed reflection on methods cannot be made here. However, they are an essential part of the results of 
the study and will be presented in greater detail in the upcoming doctoral thesis (cf. Foot note 17). 
29  Langanke/Erdmann. MRT als Studienuntersuchung 
30  Every participant was informed orally about the purpose of the interview and the planned scientific use. 
The corresponding consent documents given to the research subjects contained permission to publish the 
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Qualitative social research is an established method, and in this respect its 
legitimation is unnecessary. At the same time, this method also has its limits. The same could 
be said with respect to the quantitative methods of social research. The decisive issue, 
however, is that the usefulness of a method can only be rated in connection with its aims. The 
question remains what can be achieved with a particular method and which kind of 
conclusions can be generated and supported using this particular method:  
 
Understanding does not start with observing or collecting data or facts, but with problems. There is no 
knowledge without problems – and no problem without knowledge.31 
The motivation for using qualitative methods in this research study was to learn more 
about the effects of incidental findings on these research subjects. This aim focused in 
particular on questions about stress, and thus was intended to assist in the interpretation of the 
results of the questionnaire. The following issues needed to be clarified: How high was the 
stress caused by the report of incidental findings? What was the antecedent for the stress – the 
result itself or factors relating to the reporting procedure? However, it was never the aim to 
get general statements from the SHIP research subjects. 
Furthermore, it has to be emphasized that questions related to a deeper understanding 
of the perspective of the participants, and their concrete experiences, can be answered better 
through a qualitative rather than quantitative approach. These methods do not generate 
findings that can support the development of general statements; they do not allow one to 
extrapolate individual answers to all research subjects. 
Lastly, one should remember that with regard to issues of ethics, an individual case 
can be problematic on its own, in the sense that a relevant opportunity for improvement can 
be identified. As a matter of course, the measures of academic rigor have to be preserved also 
within empirical ethics, for the reason alone that the results will be distinct from everyday 
knowledge. Thus, a recourse to “casuistry” within the field of ethics is not unscientific as 
long it is methodically clear that individual cases cannot be presented with the claim of a 
representative nature. 
The interviews confirm the results of the questionnaires in many sections, especially 
with respect to the satisfaction of research subjects with their participation in the MRI 
examination and their willingness to participate again. 
 
B 13: Well, all in all, I think this is a good thing and I would be glad to participate again, if I can participate 
again in five years. 
Some apparently contradictory responses on the questionnaires were clarified through 
the interviews. This was the case, for example, in interviews with research subjects who said 
in the questionnaire that they did not understand the written report of the findings and found 
this stressful.  Yet, they reported that, like the majority of other research subjects, they 
preferred to be notified in a written report.32 A possible explanation for this discrepancy 
provided by the interviews was that the participants were concerned that if an oral report was 
                                                                                                                                                        
results as long as no inference from the de-identified text passages to the interviewee’s identity is possible. 
31  Popper. Die Logik der Sozialwissenaften, p. 104. 
32  Preferred form of report “in writing” = 199 respondents, “by telephone” = 1 respondents, “in a personal 
consultation” = 158 respondents. 
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given they would not also receive a written report they could take with them to their medical 
doctor. 
 
B5: Hm. You have something to show, you know. (I: hm) If somebody had called me: “Well, you are suspected 
to have this and that” (I: hm), then I said: “Okay, well then?”, you know and now I can go to my doctor (I: hm) 
and say: “Here,” (I: hm, hm) “look”. (laughing) 
The interviews also demonstrated that the procedure used within SHIP may lead to 
uncertainty, since written notification is only given in cases of a severe finding which needs 
to be followed-up, but not in cases of findings with an unclear pathological value. Not all 
research subjects realized that not receiving a notice reflects good news. 
 
B4: Well, I waited and waited that I, as promised, will get a written result, like I got for all the other 
examinations (I: hm), but so far I haven't got anything (I: hm), that's not, well, er, what I've expected. 
The following example illustrates a special case where a participant was told in the 
final consultation that possible indications of an aneurysm were detected. However, this 
respondent did not receive a written report of findings. 
 
B24: Well, let's say in the relatively short final consultation, I had only 20 minutes with the doctor. In that time I 
expected a written or detailed, er, result, you know. And I took part more than one year ago. It was DDMMYY 
when I was there (I: hm). That's why. And because he said certain things because of the aneurysm or something, 
then you start worrying. Well, okay, for a short time and than you suppress it and you go back to the daily 
routine (I: hm) ..., you know. 
Moreover, on the basis of the data from the interview it is possible to identify other 
stressful factors that were not anticipated stress factors, and also to identify more precisely 
what caused the stress has and how it affected the individual. 
For some research subjects it was the time between the examination itself and the 
receiving of the report of incidental findings which was unpleasant:33 
 
B21: which was almost three hours, I think I had lain there 2.5 hours, that was okay. I don't mind being in that 
tube. That was perfectly okay, I like it, I would do it again any time. (I: mhm) The evaluation was okay, too. (I: 
mhm) When I suddenly received a letter recently, it was in February and in September now, from the MRI. That 
I really should do a mammography, because they detected something. I thought their diagnosis was mistaken. At 
first, I looked into my calendar. When had I been to the MRI (I: mhm)? I cannot believe it (I: mhm). I really did 
count 29 weeks. Well, I had written down every appointment. (I: mhm) 
I: X [date] is in my documents. 
B21: Yes, and then I counted. I did have a treatment on the 28th. I think, on September 25th I got the letter. (I: 
laughing) And then I thought, it's over now. (I: mhm) And if they wrote seven millimeters, in seven months the 
cancer doesn't grow only one millimeter, that can be far more. 
I: What did the report read exactly? It was written that you have an expanding lesion? 
B21: “detected in the right breast, 9 o'clock, a seven-millimeter hardening which needs clarification by a 
mammography.” (I: mhm) Well, I pulled out all stops, of course in order to do a mammography. I had an  
 
                                                 
33 One reason for the long time of waiting until the final analysis of the MRI images and until the incidental 
findings are mailed is the high quality standard within SHIP. This standard includes an independent 
radiological follow-up and multiple diagnosis. Moreover, the Advisory Board may be contacted. 
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appointment at the university hospital right the next day. Well, and then they came to the result that, fortunately, 
there wasn't anything 
This respondent was, despite her long wait during which she did not think of the 
findings, lucky in two ways. Firstly, she received the report at a time when she could act 
immediately and make an appointment for clarification. Secondly, she actually got an 
appointment right away so that one day later she had the “all clear.” 
In contrast, there were cases where the people concerned where highly stressed 
because the time of notification was very unfavourable. This is shown by the following 
example when the day, a Friday, had already begun with an accident for the participant: 
 
B20: ... we wanted to visit our daughter in X that Friday, who was only living there for two months. (laughing). 
And we had imagined our weekend in a different way. [...] I know, the child will come home any moment and 
alone (laughing) her facial expression. (I: Mhm) What followed was the disappointment that we definitely can't 
go (I: yes). And then she got the mail from the mailbox and only the fact that she put the envelope down, I did 
not want to open the letter. (I: Mhm) Because I thought, if I have, well, I didn't expect at all to receive anything. 
I had zero expectations. (I: Yes) As I said, because I assumed that all in all everything was okay and I thought, if 
I receive anything, something is wrong. I wouldn't have thought that it would be a finding concerning the breast 
again (I: Yes). I opened it. Well, we wanted to eat then but whatever (I: laughing). (laughing) I wasn't hungry 
anymore. Not at all. And while reading I knew somebody is turning at the clock. You know, my mind ceased, for 
a bit. You refuse to believe it, and at the same time you have a tremendous fear because you don't want to go 
through that again. It has been so nerve-straining and then you think, ‘crap,’ again at the end of the year. There 
were so many thoughts and questions running through my mind which I can't reproduce. (I: Mhm) I worried 
most about the fact that my daughter was there because I tried to keep her out of that. (I: Yes). Because, she was 
14 and then you try to withhold the information as long as possible. (I: Yes). () (laughing) (...) And at that [B20 
crying] moment she knew how serious it has been in January. 
In some cases research subjects were stressed by the period of time they had to wait 
until the suspicious finding could be clarified. It was not unusual for the clarification to take 
several weeks. For the respondent above, the clarification took place like this:  
 
B20: The time frame was somewhere, you went there, after my gynaecologist persuaded me to do a tissue 
sample (I: Mhm). Oh, we do another MRI and then, and then the MRI should be sometime after six weeks 
somewhere. I said “This can't be true” and you are emotionally at the end (I: Mhm) and you actually hope that it 
will be quick. (I: yes) And when they say we do another MRI in six weeks. (I: Mhm) Then you think, that you 
won't get through this. (I: Mhm) Because, and I really was emotionally at the end, I didn't have any strength left 
to hide it from my family except my husband and to come up with a new story why we have to go to Greifswald 
again. That is so exhausting because, my sister had malignant breast cancer twice (I: Mhm) and then you try to 
keep your feet still (I: yes) and to not disturb anyone as long as you don't need to. (I: yes yes) But, nobody 
involved in science understands that. Here we go again (...) I had the feeling, it is only research, and I really had 
the feeling “well, we are only here because of statistical reasons and well” 
Another circumstance leading to stress for the research subjects is the content of the 
written report. The structure of the notification does not allow for an explanation that, for 
example, the results are preliminary and possibly represent a false positive. Furthermore, it 
does not take account of the “art” of report information, as established in fields like 
oncology. There are psychologically-based approaches which can be used to deliver serious 
messages (“bad news”) appropriately. When a finding does indicate a cancer or other life-
threatening disease, according to these approaches a face-to-face conversation among the 
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patient, family members, and doctor has to take place.34 The fact that the written report of 
findings leaves people concerned, but with no way to answer their questions about their 
future and their health, was demonstrated clearly in this case. 
However, the story of respondent B20 regarding her participation in the whole-body 
MRI examination contains two more aspects which are relevant for this study: 
First, it was clear that the participant thought that information she provided to the 
research personnel in the MRI examination centre would be taken into account in the course 
of diagnostics:35 
 
B20: Well, let's say, beforehand you are asked some questions before going to the MRI. He asked for any 
problems, for any surgeries or whatsoever. I think such information is used afterwards for the evaluation of the 
results or it should be considered to clear up any misunderstandings. If somebody, okay wait, I have to explain 
this. 
I: I think I know what you mean. 
B20: Let's say, if I hadn't said anything about my surgery then he wouldn't have made any statements because of 
the findings, well no, that's not true either. He would have come to the conclusion that there is something, just 
like that. (I: Mhm) But because he knew, from the former survey (I: yes), one would have this drastic statement. 
One should have written that the MRI of the breast provided some uncertain results, please let this be clarified. 
(I: Mhm) But to come straight forward with this, I was scared. I don't blame you that the device didn't or that he 
maybe saw something different. (I: Mhm) Because, the images are maybe different (I: yes) from the ones from 
the mammography (I: yes, yes). But because he knew that a surgery was done, diseased tissue was removed 
there and a new one developed, despite all that the classification was almost malignant. Maybe, the report 
should have been written in a different way. There is, do you understand? (I: Mhm). There are some 
discrepancies, please let the finding be clarified or whatsoever.  Definitely, I would have appreciated not being 
placed in that position. 
The respondent's assumption that the research interviewer was taking a medical 
history for care has to be interpreted as evidence of TM. There were a number of other hints 
of TM in the interviews. A detailed discussion of these statements, and the uncertainties 
associated with their interpretation, cannot be fully addressed here. 
We can also see that the interview with respondent B20 raises a number of issues 
related to false positive findings. This issue is important because, on the one hand, it is 
problematic that the research subject did not understand information she was given that the 
whole-body MRI examination can result in false positive (and also false negative) findings. 
On the other hand, though, it is not possible to directly clarify unclear findings in the 
MRI examination centre. Immediate follow-up is forbidden by the ethics committee because 
the hospital is not allowed to generate patient visits through SHIP. This circumstance leads to 
a period of stressful waiting for some research subjects. 
This is also concerning because controversy remains around the sensitivity of the MRI 
for certain organ systems. If, for instance, an anomaly of the breast is detected in a SHIP 
participant using the whole-body MRI, this person receives a report about the incidental 
findings, and afterwards should consult a local doctor. This doctor will then order a 
mammogram. If this mammogram does not show any anomalies which need further 
clarification, it is, as a matter of course, assumed that the MRI generated a false positive 
                                                 
34  Cf. in particular Fallowfield/Jenkins. Communicating, or Baile et al. SPIKES. 
35  Taking an informed consent consultation for a medical interview has to be classified as a hint of TM, too. 
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result. However, this conclusion is only sound if the devices used in 
gynaecological/radiological practices, where a mammogram is done, are sensitive enough to 
really confirm or disprove the finding from the MRI. This is a controversial issue within the 
field of radiology. This conclusion that a false positive result has been generated could easily 
be reversed if it is proven that the MRI is more sensitive than mammography in detecting 
neoplasms of the breast. 
Summary of Results 
Only three percent of the research subjects stated that the waiting stressed them “quite a lot” 
or “very much”. 25% of those who received a report about incidental findings stated that they 
felt “moderate” or “heavy” emotional stress caused by this notification. The analysis of 
interviews with those who reported very high stress in the questionnaires showed that the 
reasons behind the stress can often be identified. From this, we can conclude that the stress is 
not caused only by the result itself or the consequences following it. Instead, the following 
stresses that were observed could be preventable or reducible: 
a) stress resulting from the policy no written notifications are sent if no anomalies are 
detected 
b) stress caused by waiting until the report is received 
c) stress caused by the content of the report 
d) the long wait following the report until the finding can be clarified. 
Moreover, it has to be emphasized on the basis of the study results that satisfaction 
with participation in the whole-body MRI is overall very high and that those research subjects 
who were very stressed were still willing to participate again. 
When asked to identify risks and disadvantages, many participants cannot think of 
anything - even if, for instance, if they had to endure great fear (in retrospect unnecessarily) 
because of a false positive result. This is also seen as evidence for TM, which would be 
characterized by an overvaluation of the individual benefits of participant and an 
underestimation of risks and disadvantages: 
 
I: So, what outweighs is... 
B20: The value. 
I: The value. 
B20: Yes. 
I: Despite everything. 
B20: Despite everything. 
I: Okay. 
B20: Yes, well, as I said, there is always a little fear left but, after all, I am more calm now. 
Research ethics implications for GANI_MED 
A significant aim of this study was to take lessons learned from these findings and apply them 
to the development of GANI_MED. While the findings themselves are observations, we 
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could use them in the development of policies by linking them with ethical principles related 
to human research subjects (cf. 6.2).36 
An example of a policy informed by these findings is the institution of regular 
trainings for research staff conducting informed consent sessions for GANI_MED. This 
trainings focus, among other topics, on sensitizing staff to the problem of TM. 
Given that the GANI_MED project also involves MRI evaluations performed for 
research, rather than clinical care, purposes, we developed a set of policies designed to guide 
reporting of incidental findings: 
 
 We developed and distributed a detailed set of standard operating procedures (SOP) 
for reporting incidental findings. 
 The process of notification was designed in consultation with psychologists and other 
experts experienced with “breaking bad news.” 
 Research subjects with no identified anomalies are explicitly notified of this finding. 
This notification also contains an explanation that pathological findings can be 
“overlooked” in these studies, and a recommendation for participants to continue 
routine check-ups and to consult a doctor if they develop any new symptoms.37 
 Notifications are not provided in written form alone unless circumstances prevent 
notification through other means, such as when the participant cannot be reached by 
phone within a reasonable time, or when the participant has explicitly requested this. 
 Participants are called to schedule an appointment to have a face-to-face consultation 
in which their findings will be returned. Information about the finding is not provided 
by phone. 
 A set of guidelines define the period of time that may pass between an MRI exam and 
the report of findings to participants. If study procedures, such as reviewing images 
and scheduling appointments, fall behind MRI exams such that reports are not being 
returned within the designated period, MRI exams are placed on hold until other 
procedures can “catch up.” Alternatively, research subjects must be informed of 
delays. 
Ethics issues relevant to incidental findings 
As a summary and conclusion to this report of empirical findings, we will provide a brief 
discussion of the issues of professional ethics related to incidental findings in research. In 
addition, we will review the regulatory basis (cf. section 5) for the recommendations the chair 
of Systematic Theology, Greifswald provided to the GANI_MED team related to incidental 
findings. 
                                                 
36  Because one can only derive norms from premises which already contain norms there is no logical 
alternative to adding the commandments, prohibitions and permissions (i.e. norms) to ethics regarding 
research subjects. For the problem of “is” and “ought” cf. Wimmer. Naturalimus, pp. 965-966 for an 
introduction. 
37  For the wording of the relevant cover letter cf. Langanke/Erdmann. MRT als Studienuntersuchung, pp. 236-
237. 
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Incidental findings from MRI as a research ethics problem 
In the German-speaking space, M. Hoffmann and R. Schmücker have dealt with the ethical 
aspects of incidental findings generated through MRI exams in observational studies in their 
article Die ethische Problematik der Zufallsbefunde in populationsbasierten MRT-Studien 
(The ethical problem of incidental findings within population-based MRI studies). 
According to Hoffmann and Schmücker, the primary ethical problem relevant to 
incidental findings is not the possible stress they may introduce for research subjects and the 
possible development of a TM. Rather, they focus on the ethical conflict between the interests 
of the participants, who will possibly not be notified about relevant health information, and 
the interests of future generations of patients, who will benefit from the results of 
observational health studies. This conflict is, according to them, even more precarious 
because the report of findings compromises the validity of an observational study. This is 
because the report of findings alters the interventions conducted within the observed 
population: 
 
If a study is conducted with the intention of informing the care of future patients, then these results can be 
damaging if they methodological shortcoming lead to incorrect findings. This type of research must therefore 
follow the best available standards with respect to methodological quality.38 
In light of this opinion, one of the solutions discussed is not to report any incidental 
findings, in general. Instead, “monetary motivation” for participation should be provided.39 
An alternative solution would be to explicitly differentiate between incidental findings which 
must be reported and those that do not need to be reported. 
 
From our point of view, it is more ethically appropriate to return some results, and therefore to differentiate 
between incidental findings which should be reported and those that should not be reported. However, this 
approach would depend on additional research; it presupposes the development of an inventory of findings that 
have been evaluated for their suitability to be returned. Using such a resource study personnel could reasonably 
distinguish between incidental findings which must be reported and those that do not need to be reported.40 
The protocol for SHIP adopted this second option. Within SHIP, follow-up studies are 
used to further clarify diagnoses. In addition, an Advisory Board is used to develop policies 
and identify findings that should or should not be reported. 
However, even study settings utilizing carefully designed protocols can create a high 
level of stress for some research subjects, as the results of our study show. More importantly, 
though, incorrect assumptions concerning the personal benefit of participation can lead to 
actions (such as not attending medical check-ups) that are harmful to the participant’s well-
being. In fact, this phenomenon was more common in our sample than elevated stress. In 
light of this, and also in view of the occurrence of stress that is preventable or reducible, 
serious ethical issues are raised by incidental findings. These problems must be solved via 
applied ethics in the area of human research protections. 
 
                                                 
38  Hoffmann/Schmücker. Ethische Problematik, p. 19. 
39  Hoffmann/Schmücker. Ethische Problematik, p. 15. 
40  Hoffmann/Schmücker. Ethische Problematik, p. 20. 
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Disclosure of incidental findings from MRI as an ethical problem of human 
research protection41 
If in the design of a biomedical research study it is decided – for whatever reason – to reject a 
strict non-disclosure strategy42 and instead to notify participants of some MRI incidental 
findings, our findings indicate that certain measures should be taken in order to reduce stress 
and support a more realistic evaluation of the benefit of participating by research subjects. 
We believe everyone can agree on these measures if we agree on three basic research 
ethics norms: a) The informed consent as agreed on prior to performance of whole-body MRI 
should be treated as a contract-like agreement between the institution doing the study and the 
research subject (“contract principle”). In addition, two basic standards of fairness apply: (b) 
the requirement for transparency and (c) the requirement to minimize anticipated stress. 
Contract Principle 
Participating in a whole-body MRI within SHIP is, of course, voluntary. Research subjects 
are chosen at random and are invited to participate in the whole-body MRI under certain 
conditions. These conditions are explained in an information document and communicated 
during several face-to-face conversations. If research subjects accept these conditions and 
decide to participate, they enter into a relationship with the study as autonomous adults. This 
relation is contract-like because the research subjects may rightly expect getting something in 
return - under the stated conditions - as promised in the official document and in the 
consultation with the medical staff of the study. The main reward within SHIP is arguably the 
notification of health-relevant information. 
That one must agree to participate in SHIP and the MRI exam by entering into a 
contract-like relationship defines very little about what the content of that contract-like 
relationship will be. The contract principle places first and foremost a formal demand on 
those engaging in the contract; that both sides in the contract must keep their agreements, 
referred in the legal tradition by the famous formula "pacta sunt servanda". 
Other demands with respect to the content of that agreement become 
methodologically important when two basic ethical norms are raised in connection with the 
content of the consent and the way it is presented to participants. These norms can be 
summed up, with few presuppositions, under the heading of “fairness”.43 
                                                 
41  This paragraph refers to the basis given in the presentation by Langanke/Erdmann. MRT als 
Studienuntersuchung, pp. 209-221. 
42  A great deal of ethical and pragmatic justification can be provided to reject a strict non-disclosure strategy 
(cf. Langanke/Erdmann. MRT als Studienuntersuchung, pp. 206-207). Also Hoffmann and Schmücker. 
Ethische Problematik, p. 16 emphasize that this option is not unproblematic (selection of samples, taking 
advantage of the  financial distress of research subjects). Moreover, if a non-disclosure strategy is chosen, 
research images would have to be stored separately from clinical records, so that the ethical problem will 
not be “passed on” to those who have to work with images in the future and may discover relevant health 
information. 
43  This beginning of reason with this architecture of principles does not have a lot of premises because it does 
not refer to theological arguments or higher principles from the tradition of philosophical ethics. 
Furthermore, the principles of bioethics basis, as defined by Beauchamp/Childress (Biomedical Ethics, p. 
99-287), are not applied here to the problem of incidental findings within a research context. The reason for 
this is the fact that the “beneficence/non-maleficence” principle is not applicable for a research context. For 
instance, one could argue against the transferability of this principle with Heinemann et al. Zufallsbefunde 
and Zufallsbefunde Supplement. They say that the relation between a researcher and a research subject is 
not like the relation between a doctor and a patient so that researchers do not owe their research subjects 
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Transparency requirement 
In order to obtain an ethically valid IC research subjects and patients who participate in 
scientific studies should be able to understand a) which conditions govern their participation 
and b) which consequences of their participation can be anticipated.44 These two dimensions 
have to be distinguished. Transparency is required both with respect to the format and 
wording of the information participants are provide, and also with respect to the way the 
consequences of decisions are emphasized and discussed. 
Whoever agrees with this norm of transparency in both of its aspects must also admit 
that the IC documents should be as transparent as possible. But by saying “as transparent as 
possible” we are implicitly admitting that “transparency” is an ideal; we cannot demand that 
complete transparency be obtained in all cases. However, since transparency is the sort of 
thing can than be realized to a greater or lesser degree (an IC document can be “more or less 
transparent”), then in our research practices we can demand that transparency should be 
improved.45 
Requirement to minimize anticipated stress 
The transparency norm demands that anticipated consequences must be communicated as 
clearly as possible. On the other hand, the principle to minimize anticipated stress requires 
that anticipated stresses should at least be minimized in the course of potentially stressful 
study processes (e.g. the process of reporting incidental findings). But only anticipated 
stresses can be reduced, and the ability to minimize stress is constrained by the practical 
context of the study, e.g. the limited staff, time and finances in medical studies.46 
From our point of view, the plausibility of the requirement to minimize anticipated 
stress is supported by the fact that its validity can be disputed only at the cost of a gross 
contradiction against prevailing moral institutions, if three conditions are met: 
 
 Certain processes within the study can be stressful for the research subjects and to 
cause this stress is not the purpose of the study. 
 This stress can be, if not completely preventable,47 mitigated if the variables that 
influence this stress are known. 
 Modifications in research protocols intended to minimizing of stress can be 
implemented using the known variables with appropriate effort within the given 
financial and staffing resources without jeopardizing the purpose of the study. 
Due to reasons of space, we will not demonstrate in detail how this suggested structure with 
respect to principles of research ethics, in combination with the empirical findings presented 
in this paper, support the policies described in section five with respect to the design of 
                                                                                                                                                        
the same as patients rightly expect from their doctor. 
44  cf. also Deklaration von Helsinki, § 22 or for the German context Bundesärztekammer, ch. 5; 8. 
45  For “transparency” as an ideal and the role of TM as a practical limit of optimizing cf. Langanke/Erdmann. 
MRT als Studienuntersuchung, p. 214-216. 
46  For criteria of the possibility of anticipation cf. Langanke/Erdmann. MRT als Studienuntersuchung, p. 217. 
47  If it is admitted that stress from the report of findings cannot be absolutely preventable because the report 
of a potentially pathological finding always causes anxiety and fear. 
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GANI_MED.48 At this point it should be noted that it is characteristic for the 
empirical/normative approach of the team at the chair of Systematic Theoology, Greifswald 
to supplement classical normative argumentation with reflection on results from empirical 
research. With this combination of normative and empiric methods the chair of Systematic 
Theology contributes to what is currently discussed and disputed under the topic “empirical 
ethics”. 
Summary 
The understanding of persons who participated voluntarily as research subjects in the 
population-based SHIP in a whole-body MRI examination is not well developed, in the sense 
that they did not appear to recognize the risks and disadvantages which can be part of the 
examination. From this we may assume that they did not understand at least some of the 
information they were provided in the informed consent process. This is the conclusion of 
this empirical study undertaken to explore the aspects relevant to ethical issues in the 
reporting of incidental findings generated in the course of MRI examinations conducted as a 
part of epidemiological research. 
The analysis of questionnaires and interviews demonstrated an extremely high level 
of satisfaction and a corresponding willingness to participate again in an MRI study. Despite 
the fact that “customer satisfaction” was very high, this study also indicates that the positive 
perceptions of the study are a result of a tendency of research subjects to overestimate the 
study’s diagnostic benefit, despite being provided information to the opposite. The benefits 
they expected are not validated for many types of findings made through whole-body MRI. 
Almost 40% of the questioned participants assume that medical conditions will be clarified 
through this examination, and 10% think that they do not require further medical check-ups 
because of their participation in the whole-body MRI. These results, which show an 
overestimation of the benefit (and an underestimation of possible risks) by research subjects 
in the sample we examined can be attributed to the phenomenon of therapeutic 
misconception, a phenomenon well recognized in a variety of types of biomedical research 
studies. 
In summary, we conclude that a) the assumption that the reporting of the incidental 
findings will cause a disproportionate stress for the research subjects cannot be confirmed on 
the basis of this sample. However, from a research ethics perspective, we can say that b) 
potential stress can be prevented by various measures, such as through changes in the 
methods used for reporting results. In addition, c) the process of informing research subjects 
of the risks and benefits of research must be improved so that research subjects are able to 
evaluate the validity of results from whole-body MRI more realistically. 
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Abstract 
This paper argues that the core principle of bioethics, autonomy, is rooted both in the 20th 
century history of the development of new medical technologies as in political liberalism 
transferred to medical practices, rendering the medical decision-making of patients a 
centerpiece of medical interventions. The paper shows how the ambiguity in the 
interpretation of autonomy reflects the ambivalence of bioethics towards making normative 
claims on the moral agents insofar as these go beyond the respect for a patient’s autonomy. In 
the second part, the paper analyzes the alternative approach of care ethics, which intends to 
emphasize both the vulnerability and dependency of the patient and the medical professions’ 
responsibility to care for the patient. However, neither ‘autonomy’ nor ‘care’ ethics 
approaches can address the social and institutional mediations of today’s health care ethics; 
the paper therefore concludes with a proposal to embrace a critical social-ethical approach to 
bioethics that is based on the tradition of human rights.   
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Introduction 
Societal practices, including numerous practices in the health care sector, have radically 
changed during the second half of the 20th century. The changes certainly concern human 
reproduction, the prolonging of life with the help of modern medical technologies, and the 
social practices surrounding the process of dying. Even the concept of life and death have 
changed over the course of the last century, and a utilitarian economic reason that 
accompanied modern industrial societies since the 19th century, has reached the sphere of 
medicine, too: how we handle the human body in medical prevention, diagnosis, and therapy 
echoes the automation of other non-medical technical processes; the human corpse is more 
and more utilized for organ transplantation; but also body parts such as blood, sperm or egg 
cells, or human tissue are used in the ever-demanding processes of medical cures. Modern 
society’s hospitals sometimes resemble large industrial complexes, and even small medical 
practices may use more technical devices than a person might ever see in his or her everyday 
life. In sum, the institutional changes that medicine has gone through over the last century are 
dramatic, and it is not so clear whether medical ethics, as it is known today, embraces the 
complexities of these changes, especially when it predominantly is framed as ‘individual 
ethics’. In this article, I will show how the ambiguity of the interpretation of autonomy results 
in an ambivalence of what exactly moral claims are moral agents, namely patients, are faced 
with and I will then complement and, in part, juxtapose the principle of respect of autonomy 
with the medical professionals’ responsibility to care for a patient. Both concepts, however, 
cannot claim to address the social and institutional questions of today’s health care ethics, 
and hence I will conclude that to connect both concepts of autonomy and care with a social-
ethical approach to bioethics is the most challenging task ahead. 
Bioethics as an Answer to Societal Change in 20th Century 
Questions of bioethics are part of the broader ethical reflection that embraces different 
changes of social practices in modern societies. In the discipline of bioethics and biomedical 
ethics, which originated in Northern America in the 1950s,1 the shifts and changes of the 
medical practices due to the development and application of new technologies are examined 
in historical, cultural, or anthropological studies, including the analyses of the transformative 
processes and the emergence of new norms in different contexts. Sociological analyses 
describe societal changes, e.g. shifts with respect to values and beliefs, and psychological 
studies examine, among others, the impact of these changes on the personal identity, their 
coping strategies with illness, etc. In the traditional labor division between descriptive and 
normative disciplines, philosophy, theology and law are the classical disciplines to critically 
evaluate the normative dimension of practices by means of rational argumentation.  
While medical ethics has always been part of medical practice, it was newly 
constructed after World War II. It emerged as corrective to the crimes committed by 
physicians during the Nazi dictatorship, but with the development of new medical 
technologies, biomedical ethics began to add to the critique of disrespect for human rights the 
underlying paternalism in all traditional clinical medicine. Moreover, since individual 
                                                 
1 (Jonsen 1998). 
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freedom was largely considered to be the core social value of US society, relying on the 
physicians’ virtues and individual responsible behavior appeared not only to be dubious in 
light of the recent history but also seemed to contradict the freedom right of sovereign 
citizens in modern societies. Health care providers were more and more seen as providing the 
means for patients to realize their choices in situations of illness and disease. Furthermore, 
the principle of well-being, which had served as the over-arching norm of medical action for 
centuries and considered the core principle of traditional medical ethics, (articulated, for 
example, in the principle:  “Salus aegroti suprema lex”), seemed to belong to a paternalistic 
medical ethics rather than to the new framework of an autonomy-based ethics. While well-
being is certainly still guiding the physician’s every-day practice, it became, above all, a 
problem in the contested cases of biomedical ethics: especially in the conflicts concerning life 
and death, the course of action, it was held, should be determined by the patient rather than 
by the physician or anybody else. According to the revised biomedical ethics, respect for the 
patient’s autonomy is paramount in the doctor-patient-relationship and expected to create 
exactly the trust that is needed in this asymmetric relationship; in practice, however, this 
respect is often merely spelled out as the signature on the consent form. Nevertheless, respect 
for the patient’s autonomy reflects a radical change in the underlying concept of medical 
actions concerning the status of the traditional principle of well-being.  
The re-orientation of the traditional medical virtue ethics by way of the establishment 
of several institutional Codes of Conduct, political oversight of new technologies, and the re-
evaluation of traditional medical ethics was met by a major methodological 'milestone' when 
Tom Beauchamp and James Childress published their ‘Foundations of biomedical ethics’ in 
1977, which is now in its sixth edition, each of which responded to the critics of the 
approach.2 It was assumed that by constructing foundational “middle principles”, both the 
theoretical and practical needs of medical ethics could be met without burdening bioethics 
with the commitment to a particular moral tradition or religious belief system. The authors 
hoped that on the basis of plural traditions, the principles of bioethics could be negotiated and 
serve as a normative reference for the new discipline of bioethics. By aid of the four 
principles, autonomy, non-maleficence, beneficence, and justice, norms were to be set up for 
most changed areas of medical practice, namely ethical issues at the beginning of life, at the 
end of life, or genetic testing. Together with legal norms, the principles were supposed to 
guide the clinical decision-making procedures ‘at the bedside’. From the beginning, however, 
legal-ethical deliberations dominated the debates, framing the bioethics discourse as analysis 
about a physician’s right action and the scope of legal regulations. In the very famous case of 
Karen Ann Quinlan, for example, her parents, the legal guardians, sought to end her treatment 
after several months because she had not responded to any effort to help her regain 
consciousness – the court ultimately ruled in favor of her parents’ wishes. This case became a 
test case for biomedical ethics in the new ‘era’ of life-sustaining technologies, and unless the 
more casuistic methodology of Catholic moral theology was applied, bioethical questions 
were framed in view of liberal political philosophy. Mostly, they were seen as conflicts 
between freedom rights on the one hand – hence respect for a patient’s autonomy (sometimes 
represented by her guardians) interpreted mainly as negative freedom right, i.e. the right not 
                                                 
2 (Beauchamp Childress 2008). 
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to be hindered by the state or medical institution to act in accordance with her wishes – and 
protection rights on the other hand, i.e. an institution’s or state’s duty to protect the life and 
well-being of citizens. This conflict between different kinds of rights is not unusual in liberal 
political philosophy; what is not so clear, however, is whether this framework of political 
liberalism is appropriate in order to interpret modern medical ethical conflicts.  
Beauchamp and Childress’s book is certainly the best-known approach to biomedical 
ethics; it joins the long list of US American bioethics books that presuppose the modern 
liberal framework, even when disagreeing whether a more deontological or consequentialist 
approach should be taken. And although the book was critiqued from philosophers especially 
for its reliance on a ‘common morality’, with the spread of the discipline of bioethics to 
almost every country of the world, the underlying framework has become the most influential 
methodology within biomedical ethics. Moreover, very soon the "four principles approach" 
succeeded in providing an instrument to ethically structure complex ethical issues in such a 
way that they can be regulated. Given the heavy influence of the six editions of the book so 
far, it is probably not too far-fetched to say that it has had the intended effect, even though 
today, the question of just distribution of resources (and hence the question of political and 
economic ethics) and the challenge of global justice (and hence the relation of political ethics, 
governance, and economics) reflects a shift in the bioethics debate towards the methodologies 
of social and institutional ethics. Bioethics, it is claimed today from a Foucauldian 
perspective, is also always biopolitics, mirroring not only the historically contingent and ever 
shifting relation, for example, between religious communities and the state, but also the 
pragmatic focus of bioethics as consultant and adviser of political bodies. While these 
approaches claim that the clinical-ethical approach, which is centered on the physician-
patient relationship and their interaction, is far too narrow given the complexity of health care 
and governance of individual’s health, the principle of autonomy, as introduced in the early 
works of bioethics, is still considered to be the core principle of the discipline.3 
The critique of autonomy as preferential autonomy 
In the context of medicine the concept of what I will call preferential autonomy is defined as 
respect for the desire and the preferences of a patient – whatever these may be, limited solely 
by the respect for the preferences of others. This respect has replaced, as I said, the shared 
notion of ‘well-being’ that formed the basis of action in the traditional medical ethics. In that 
paradigm, it was the physician’s expertise that determined whether and how an illness or 
disease could be transformed into what Heinz Georg Gadamer called the ‘equilibrium’ of 
bodily functions and the subjective sense of ‘feeling healthy’.4 In this conceptual framework, 
the patient would trust the doctor or medical team to take care of the necessary steps to reach 
this status of equilibrium – or at least to try everything possible to restore his or her well-
being – at the price of not knowing or not understanding a physician’s actions.  As Onora 
O’Neill has argued convincingly, ‘trust’ is a necessary ingredient of the doctor-patient-
relationship,5 while mistrust is poisonous for a relationship that exposes the one partner to 
                                                 
3  For a good overview of the discussion on autonomy in bioethics cf. (Tauber 2005). 
4  Cf. (Gadamer 1996). 
5  Cf. (O'Neill 2002). 
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potentially painful physical and psychical interventions by the other – in a culture that values 
individual freedom highly, a return to the traditional virtue-ethics paradigm seems to be 
impossible unless it leaves enough space for information and consent. While this is not 
questioned, the exact interpretation of autonomy is subject to many contemporary debates. 
The concept of a patient’s preferential autonomy, which echoes the social value order 
of Western societies’ individualism, requires a medically and ethically competent patient: If 
the choice is considered as a patient’s self-determination of action, this changes the 
physician’s role dramatically, even reversing the asymmetry between the doctor and the 
patient in matters of ethical decisions. Again, in more traditional settings, this may not 
become a big problem, because it will still be the ‘well-being’ that drives the decision and the 
patient will most certainly rely upon the expertise of the physician. But in the biomedical 
setting of today’s health care provisions, this may easily change, because health and illness 
become much more ambiguous concepts: for example, in genetic testing, dispositions to 
develop diseases in the future may serve as cause for actions (preventive screenings, 
abortions, or preventive surgery are examples of such interventions), even though no actual 
disease is at stake. The ethical decision can therefore not be guided by a person’s well-being 
as equilibrium of health (already) disrupted by a disease; rather, the decision involves the 
assessment of risks and the probability of a disease to manifest; decisions may involve the 
assessment of one’s future quality of life, as this is, for example, the case in prospective 
living wills. In all these cases, medical experts can give statistical information, but since 
quality of life is difficult – if at all possible – to quantify, the necessary decisions do not only 
concern ‘objective’ criteria but rather individual preferences of how a person wishes to live 
with regard to possible medical options. In such a scenario that is rather the standard of 
biomedical decision-making than the exception, doctors and patients may in fact rather be 
‘moral strangers’ than sharing a social understanding of health and disease.6  
Since the value of an individual’s freedom to act is considered as the ‘highest good’ 
of the modern (Western) ethics that in return shapes the normative principle of respect, the 
flipside of the value of individual autonomy is therefore ethical pluralism. Tolerance or 
respect is the normative response to this pluralism. As a result, the dominant liberal medical 
ethics emphasizes the normative implication of autonomy for physicians or caregivers: they 
not only need to refrain from any action that could interfere with the patient’s own desire or 
interest but also from reasoning with the patient about underlying value judgments of their 
interests. Conversations are to be ‘non-directive’ lest they risk manipulating the patient’s 
sovereign choice. The effect of this change is a moral ‘neutralization’ of the doctor-patient 
relationship, and often health care institutions retreat to a formalized procedure to ensure a 
patient’s consent to medical interventions.  
Despite of the problems to implement appropriate procedures, preference autonomy 
seems to ‘fit’ well with modern societies.7 However, while individuals may interpret their 
preferences as 'authentic' desires, they are in fact socially mediated: preferences are at least in 
part shaped by social values and social norms. As I have argued, in an environment of ‘moral 
                                                 
6  For H.T. Engelhardt modern societies ‘produce’ moral strangers and this is a strong motive for him to 
establish the principle of respect for the autonomy of all in his influential book: (Engelhardt 1986). 
7  For a defense of preferentialism from a utilitarian perspective cf. (Singer 2011); for a critique of the 
‘modern self’ cf.(Taylor 1992, Taylor 1992). 
44 
strangers’ or moral pluralism, these mediations can hardly be addressed – but this does not 
mean that the ‘liberal self’ comes without attributes: the concept of preference autonomy 
implicitly (or explicitly) assumes that a patient is a particular agent: sovereign, free, and well 
able to choose among several goods. But this self-concept turns out to be merely an idealized 
image of the modern citizen that political liberalism has depicted; while political liberalism 
turns to the relation of the individual and the state, bioethical liberalism is heavily influenced 
by the citizen as participant in civil society. In modern societies, these are for a good part 
defined as market societies, in which the individual will cooperate with others while pursuing 
her own interests – and it is this social practice that liberal bioethics seems to presuppose, 
while transferring it to the sphere of health care. Preference autonomy may be an appropriate 
concept when applied to the consumer market, but it distorts the reality of patients in need of 
help, because it cannot attend to the vulnerability that accompanies illness, and it cannot 
attend to the constitutive relational and social character of human life. To this aspect, I will 
return below. But there are other reasons to question an over-simplified interpretation of the 
concept of autonomy from an ethical perspective:  
First, freedom as such may well serve as an anthropological concept to describe the 
conditio humana – but without further specification it cannot serve as a moral principle. For 
this reason, Immanuel Kant defined autonomy not along the line of individual preferences but 
rather along the line of moral reasoning: moral autonomy, as a basic category in moral 
philosophy, is the concordance of the agent’s moral maxims (the action-guiding, yet non-
categorical, preference-based principles) and the categorically binding moral law, which 
ought to be comprehensible by everyone; defining autonomy as the foundation of morality, 
Kant did not think of the individual’s freedom to pursue her happiness; rather, he addressed 
the freedom of a person to ‘construct’ the moral laws that regulate (and motivate) actions, 
analogue to natural laws that cause events to happen. The distinction between preferential 
autonomy and moral autonomy is therefore crucial: preferences as such have no moral 
qualification; hence it can be right or wrong to respect them. In contrast, moral autonomy is 
practical freedom, demanding not only that an agent herself acts morally (in accordance with 
the categorical principle, i.e. justified with a claim to universal validity) but also that she is 
respected in this ‘dignity’ – the capability to act morally.8   
In the last decades, this moral approach to autonomy was elaborated further from two 
important sides without turning to the concept of preferential autonomy. Discourse ethics 
critiqued the Kantian justification procedure for its monological structure of reasoning, and it 
transformed the process of reasoning to a dialogical procedure of deliberation, as 
argumentative discourse. Although this approach was developed as a political ethics, it can be 
useful for biomedical ethics, too: in clinical ethics, it is, for example, echoed in the concept of 
‘shared decision-making’, which transcends the imperative of non-directive interactions. 
Second and more radically, however, phenomenological ethics questioned the 
universalization of maxims. It takes up Kant’s turn to obligations and reformulates it as 
                                                 
8  In recent years, Ch. Korsgaard has supported O’Neill’s Kantian approach that prioritizes duties over rights, 
arguing that Kant’s ethics is not only necessary for moral reasoning, but it can indeed be constructed as a 
‘necessary’ part of a person’s self-identity. Cf. (Korsgaard 2009). 
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responsibility.9 In this approach, the response to the ‘other’ takes precedence over the self-
related actions that include the other via universalization only. In the bioethical context this 
means that both patients and health care providers need to ask what responsibilities arise in a 
given situation; a patient may even conceive of herself as other, resulting in the obligation to 
care for herself, while physicians will need to ask what they ‘owe the other’, the patient. 
Autonomy is thereby closely linked to the concept of responsibility; the latter, however, is 
better equipped to attend to a patient’s loss (or lack) of sovereignty that so often accompanies 
the experience of illness.  
A second reason to transcend the concept of preference autonomy concerns the 
concept of free choice in the context of health care services. Biotechnologies which have 
become more and more part of the current medical practice are a good example of the easily 
crossed line between the rhetoric of ‘free’ choice and the shaping of this choice by market 
strategies; for medical products are often very expensive, and they are predominantly owned 
by companies that need to make profit. Such companies have a vested interest to identify 
potential consumers for their biomedical products or procedures in preventive, diagnostic, 
and therapeutic medicine. Whatever is declared to be in the patient’s “interest”, is also part of 
and subject to a system of economic incentives and motifs, all based on the assumption that 
one will first develop the goods that then will find the consumer. Seen from the institutional 
or social-ethical perspective, however, individual choices are not only mediated socially but 
rather, needs are sometimes created rather than discovered, in order to create a market for its 
products.10 A powerful example of this dynamic within the medical sector is the drug Viagra 
that was developed as medication for a specific sexual condition, but once it marketed, it was 
broadly advertised as a lifestyle drug for an ageing male population. Within few years, the 
drug has radically changed the attitude towards and the perception of sex in an ageing 
society.11 Commodification, it seems, has also long taken the lead in reproductive 
technologies: For example, sex-selection in early pregnancy was developed as part of medical 
genetics to determine sex-related risks, as in Duchenne muscular dystrophy. By now, 
companies sell test kits for no more than $25 online. Adding lab fees and shipping costs, 
these tests can be bought for $250-300. According to a review study that was published in 
August 2011 in the Journal of the American Medical Association (JAMA), non-invasive 
blood-tests are highly reliable with respect to the determination of the offspring’s sex; they 
may pave the way to offer future parents the choice to determine the sex of their future 
child.12 Furthermore, in several countries, the most popular of which is India that has a 
booming market in this area, children are purchased from surrogate mothers changing the 
‘conception’ of a child. With respect to enhancement technologies, biochemical or 
neurological stimulants are heavily marketed. As a clear-cut separation between patients’ 
needs and consumers’ interests is impossible, the distinction between treating a patient and 
                                                 
9  (Levinas 1998). For a more thorough analysis of the critique of liberal bioethics via an ethics of 
responsibility cf. (Haker 2008). 
10  Medical sociologist Peter Conrad argues that the transformation of the ‘traditional’ medicine to a market-
oriented medicine is the most striking feature of modern medicine – this analysis raises important questions 
for the concept of preferential autonomy as brought forward by Anglo-Saxon bioethics. I will return to this 
below. Cf. (Conrad 2005, Conrad 2008). 
11  Cf. (Loe 2004). 
12  (Devaney 2011). 
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satisfying a consumer is more and more blurred. Nevertheless, the rhetoric and health renders 
the marketing of new products or services more acceptable. Today, commodification in the 
health care sector is a challenge that bioethics must attend to in its overall analyses of 
individual autonomy.13 
A third argument that questions the interpretation of autonomy as preference 
autonomy concerns the cultural shaping of basic concepts of human existence by the so-
called life sciences. In contrast to the ever smaller role that cultural and religious traditions 
play in interpreting human existence, the scientific approach to human life in biology, though 
necessary within that discipline, becomes the dominant paradigm to understand human life – 
and shapes a new cultural understanding. For instance, in the 1960s, human death was 
defined as brain death, at least partly in order to enable organ transplantation, with the result 
that today ethical questions concerning the treatment of brain-dead persons predominantly 
concern the ‘harvesting’ of their organs and not, for example, new ways to deal with the 
dying person in a highly automated environment.14 In the Life Sciences, human body parts, 
tissue, or gametes are necessarily conceived as mere body material in order to have them 
available as medical resources; the existential perspective may easily be dismissed. From an 
ethical perspective, this necessarily reductionist scientific view must be complemented with 
the phenomenological insight of ‘embodiment’: a patient not only ‘has’ a body among other 
bodies; a patient ‘is’ her body that she experiences as ‘hers’ in a non-instrumental, 
experiential way.15 Given the dominant perspective of biology as normative framework in 
defining the meaning of human life, the human body becomes a crucial site of 
anthropological self-understanding. In Foucault´s analysis of power this dynamic has been 
appropriately described as “biopolitics.” The normative shifts are not based on power as 
domination but rather pass through the bodies of individuals. They are adopted “free-
willingly,” but still form “regimes of power,” which Foucault described as 
“governmentalities”.16 An ethics based purely on the respect of individual autonomy has no 
means by which it can analyze this self-induced dynamic of power.17 Bioethics must, 
however, be able to attend to the psychic, social and cultural dimensions which shape the 
overall understanding of human existence, and it needs to contextualize the life sciences’ 
perspective in this endeavor.  
Without a critical method of reflection of these dynamics, ethics loses its capacity for 
the normative analysis and assessment that ultimately is aimed at orientating individual 
agents in their actions. Contrary to philosophers who want to merely embrace the Kantian 
concept of moral autonomy, I am convinced that Kant’s approach alone is not sufficient to 
normatively address, for example, the commercialization of biomedicine and the cultural 
transformation of our societies by way of the life-sciences.  
                                                 
13  (Honneth 2008), (Dickenson 1997, Dickenson 2009). 
14  The role of relatives in the process of determining the brain death of a person is almost always reduced to 
the decision about organ transplantation; the dramatic experience of the death of a beloved person in the 
environment of an IUC is not part of the debate and left to psychological studies. Ethics, however, also 
concerns the ‘ars moriendi’ and includes practices of accompanying a person’s death. In the legal-ethical 
framing of bioethical questions, there is not much room for such reflections.  
15  (Vetlesen 2009, Merleau-Ponty 1962). 
16  (Burchell 1991). 
17  The dialectic of power as both heteronous and  self-constituting feature is explored further by (Butler 
1997). 
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Care for the ‘vulnerable’ as corrective of an ethics of autonomy? 
Let me now very shortly turn to the ethics of care. For the last decades, the ethics of the 
liberal understanding of autonomy has been criticized from yet another angle that I have not 
presented so far: feminist ethics as well as several religious ethics approaches claimed that 
the emphasis on autonomy ignores the relatedness and interdependency of persons.18 
Furthermore, these critics hold that the autonomy model stresses a self-confident agent who 
knows what he wants (sic!) and demands that his interests are met by caregivers and medical 
professionals – all this in a situation that is in fact more defined in terms of dependency, 
vulnerability, and suffering than by the sovereignty of agency that the autonomy concept 
suggests. As much as respect is needed in order to acknowledge the freedom-rights of 
patients, their need for the care provided by others must not be forgotten. Starting with 
different kinds of inter-relations between persons, their inter-dependency and the specific 
vulnerability of patients in the context of medical services, the ethics of care concludes: 
ethical reflection must not start with the assumption of an ‘atomic’, i.e. un-related, a-social 
self-determination. As I have said above, phenomenological ethics, too, has presented a 
radical critique of autonomy as conceptual starting point of either the self or of ethics, 
reversing ethical reflection from the ‘ethics of the self’ to an ‘ethics of the other’, or an ethics 
of responsibility. This reversal seems to resonate well with some newer versions of an ethics 
of care, because it precludes bioethics from being received as just the return to an ethics of 
common values, shared understandings of well-being or ‘objective’ standards of care. Even if 
the concept of individual autonomy may be useful in other contexts, ethicists have claimed 
that it misrepresents the existential status of a person who in the medical context has turned 
into a patient. 
But it is not only the reversal from rights to needs and responsibilities that matters in 
care ethics. Defenders of this approach argue that different kinds of principle-based moral 
theories are constrained by the rationalistic frameworks of justification so that they miss the 
point of moral practice.19 Ethics, they claim, concerns the sometimes monological, more often 
dialogical or collective deliberation about the appropriate response to a given situation – and 
this response cannot be found in a textbook of normative reasoning but needs to be partly 
informed by the given situation, the persons involved, and the ‘creative imagination’ about 
the patient’s well-being.20 According to this approach, the patient’s right to be cared for (i.e. 
to be assisted in her autonomy, flourishing or well-being) transforms into a positive duty: it is 
not enough only to passively respect the other’s needs but they must be met by way of action, 
response. This response, however, must be acted out as ‘responsible response’. Since any 
action needs to be justified, the patients’ needs, the agents’ values and conviction, 
professional standards, ethical principles and legal constraints all enter into the ethical 
                                                 
18  Cf., among others, the following studies that emphasize the concept of care: (Clement 1996, Conradi 2001, 
Donchin 1999, Held 1995, Levine 2001, Mackenzie 2000, Kittay Feder 2002). 
19  Cf. for a summary: (Dodds 2007). 
20  I call this ‘creative imagination’ because I do not believe that we always have clear understandings of what 
our well-being may involve. However, in a given situation that constrains the scope of action by various 
conditions, I am convinced we come up with at least the relevant factors of well-being. Yet, we may well 
prioritize the elements differently. But that is a concern for the actual decision-making process and not for 
the notion of our well-being.  
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analysis;  the patient’s perspective alone is certainly not to overrule all other deliberations, 
while his or her dignity, spelled out in specific rights, is in fact inalienable.21  
So, if care ethics is concerned with responsible responses that are meant to meet the 
needs of another person – how are these defined? Susan Dodds argues that care is still to be 
oriented towards a person’s or patient’s autonomy:  
 
The provision of care can be defined as activity undertaken with the aim of providing 
an individual with the social, material and emotional supports that either allow that 
person to flourish as far as is possible, or (as far as possible) to bring the life of a 
person with some recognized physical, cognitive, psychological disability into a 
position where their autonomy can be realized.22  
Dodds is quick to add that autonomy is not always the goal of care. In some cases it may well 
be a rather restricted meaning of flourishing, as is the case in the care for persons with severe 
mental disabilities, or people in the so-called persistent vegetative status, or persistent coma. 
Dodds’ normative basis, however, is the claim that the existential vulnerability relates the 
care-giver to the care-receiver in an un-altruistic way because of the underlying inter-
dependency or a shared vulnerability that differs only in times and degrees of the need. Most 
care-ethicists seem to share this view.  
As much as this re-turn to the concern for the patients’ needs can be embraced, it can 
be doubted whether its inherent focus on personal relationships can address the current 
challenges of the medical system. Rather, a systemic, ‘managerial’ ethics has taken over, it 
has been argued, “setting the stage for formations of collective actions by a large number of 
individuals”,23 whose individual actions must be organized and coordinated. Furthermore, 
contrary to its’ proponents’ implicit assumption of inter-dependency, its normative status in 
medical ethics is at least as unclear as in the counterpart approach of an ethics of autonomy.24 
For care ethics may easily fall into two traps: first, caregivers may take the patient’s 
articulation of her need as the guiding norm of their provision of care – in this case it is not 
different from taking serious a patient’s interests as articulated in the liberal autonomy-based 
ethics; second, the caregiver might determine the patient’s needs herself and shape the 
content, scope and limits of what she considers to be a responsible care without giving the 
patient’s voice priority. The only circumvention of the first trap is to engage the patient in a 
conversation about needs, rights, and obligations, the threshold of acceptable actions and the 
limits of what the caregiver is able or willing to give. This could be called a hermeneutical 
process about the specific needs and actions, including values, rights, duties, and respect on 
both sides. This brings us back to a critical hermeneutics that tries to decipher the social 
norms that may inform the emergence of needs, and the competency to weigh the personal 
narratives to the normative, universalistic rights’ perspective.  
To avoid the second trap, paternalism, is certainly more difficult when a 
hermeneutical conversation cannot take place, and imagination or empathy must complement 
                                                 
21  Cf. for a recent collection of essays concerning the theory of dignity and its possible foundational status in 
bioethics (Pellegrino 2009). 
22  (Dodds 2007), p. 501. 
23  (Stirrat 2005), p. 128. 
24  For an insightful critique of common care-ethical approaches cf. (Paley 2011). 
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the normative reflection. This may be the case when patients are not able to articulate their 
needs due to their medical condition, their young age, or mental capability. Since we can 
almost always presuppose that patients are not unrelated beings but embedded in different 
webs of relations, it may often be feasible to consult with these relevant other persons, and 
bioethics has developed (along the lines of an autonomy-based ethics) the so-called standard 
of best interest that care ethics may counter with the standard of best care. The normative 
limit of the care-ethics, however, is the same as it is for the ethics of autonomy: this is the 
inalienable dignity of the patient that must be respected, and that must be particularly 
respected in situations of increased vulnerability. Everything is dependent, then, on how we 
can conceive of dignity in the context of bioethics, and moreover, how dignity is spelled out 
in different kinds of human rights. 
The return of the question of methods 
The limits of both autonomy and care ethics approaches show that bioethics needs to broaden 
the methodological framework within which medical-ethical questions are negotiated. I see a 
trend in contemporary approaches to bioethics to rather describing various individual values 
and social norms than normatively evaluating them. Ignoring this specific task, more and 
more empirical studies replace normative analyses; they tacitly operate on the belief that a) 
since pluralistic societies need to respect the patient’s will, empirical studies can shed light on 
what individuals think; furthermore, surveys exploring a population’s stance on particular 
practices are instruments of deciphering social values and norms; these, in turn, are taken as 
an important basis for legal regulations in democratic societies. The flaw of this approach is 
not so much that its informative value is limited – this holds true of any empirical study or 
poll; rather it confuses the majority votes with the validity of moral claims. A critical ethics 
based on the foundational principle of dignity and human rights cannot knuckle down to 
majority views; rather, it has to argue for the justification of moral claims. Many studies in 
bioethics overlook this task of normative justification altogether. But while ethics certainly 
needs to interpret existential experiences and social practices, it also needs to offer a 
normative framework to determine, for example, the correlation of freedom and 
responsibility.  
Certainly, descriptive and comparative studies are an indispensable part of what I call 
a critical hermeneutical ethics. As such, bioethical approaches and approaches in cultural 
anthropology, ethnology and social sciences will coexist parallel to each other, and they will 
strive to overcome the current deficit that often exists because they remain unconnected.25 
However, in addition to the descriptive depiction of normative orders or the critical analysis 
of social practices, the reflection on normativity is indispensable. Hence, the critical 
hermeneutical ethics is to be complemented with a normative ethics that I call a historically 
sensitive universalistic human rights approach. 
A number of bioethicists who have confronted the question of normativity refer to a 
theory of a deliberative democracy, leaving foundational ethical questions to a discourse 
model of decision-making. But as much as this may be a possible (democratic) procedure for 
political decisions, it does not suffice for the bioethical normative reflection. Insofar as ethics 
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is not political theory, even though both disciplines of philosophy are connected in their 
objects of research, the equation of consensus and the justification of moral claims is flawed. 
For, to mention but one critique of any kind of discourse ethics, which is raised by feminist 
ethics as well as critical ethics: the emphasis on discourse is not as innocent as it appears to 
be, because it underestimates the factual power relations and power structures, especially 
with respect to the fundamental categories of sex, class, or race.26 This deficiency seems to 
shake the entire architecture of a procedural ethics that is founded on the capability to 
articulate one’s claims in the public realm, and brings us back to the underlying conflict of an 
ethics of autonomy and an ethics of responsibility. Although I certainly cannot argue for it 
here, I believe that the most promising resolution to this methodological dilemma is a 
combination of a critical hermeneutics (that examines the factual inequalities, social norms 
and normative orders) and the universalistic human rights approach (that is the underlying 
framework of discourse ethics, too, which is constructed to secure the freedom rights of any 
participant in social practices). 
For such a qualified universalism based on human rights theories, the varying 
contexts are acknowledged in informing the understanding of “human existence”. The 
fundamental principle of this approach is human dignity, spelled out in the various kinds of 
human rights: basic rights, protection rights, freedom rights, and claim rights. The advantage 
of this approach rests on the fact that human rights ethics does not necessarily assume the 
theoretical coherence of values but takes at its starting point the historically established 
human rights frameworks. They refer, for example, to the qualified and codified catalogue of 
Human Rights Declarations, which the vast majority of nations have acknowledged and 
confirmed – and which are open to additions and further differentiation. In my own view, the 
normative implications of historical, yet critical reasoning must be spelled out more 
specifically in this endeavor,27 and this can only be done in closely examining and adhering to 
historical experiences: as the origin of human rights lies in a specific European tradition and 
historical experience, this can and should be explicated and articulated. This origin does not 
weaken the justification, to the contrary, it strengthens it: instead of viewing human rights in 
terms of a naturalization of ultimately Eurocentric values, their origin ought to serve as a 
point of departure in a dialogical process of understanding and appreciation, contextualizing 
the normative framework within a specific historical experience it and opening it up to 
comparative studies. Justification of normative claims cannot be successful without this turn 
to historical reason; but historical experiences alone cannot legitimize moral claims without 
turning to a concept of ‘qualified universalism’ that is grounded in the equality of all human 
beings but takes its starting point in the experience of injustice.28 While this normative 
                                                 
26  For a defense of this Kantian-based and yet procedural normative ethics, see (Forst 2007), and a critique of 
it in (Honneth 2011). 
27  (Honneth 2011). 
28  Cf. (Shklar 1990).This is where the theological-ethics discourse should be located as well. The Christian 
ethical “Option for the Poor” refers to a theologically grounded partiality, which focuses ethical attention 
on marginalization and exclusion, on unequal structures and the perpetuation of unequal balances of power. 
This ethical focus within the Christian ethic is connected to the attribute of God´s compassion and concern 
for justice, which translates into a practical involvement and engagement for others (Haker 2001). On a 
personal level, compassion means a concern for oneself and others; on the societal level, it means active 
solidarity with discriminated groups in achieving and reviving recognition: (Haker 2009); and on the 
institutional level of justice policies, it must be spelled out as negation of injustices. Injustices, not justice, 
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reflection concerns the very foundation of ethics as such, we can still try to see whether we 
may use it as the starting point of the normative reflection in bioethics, too.  
In conclusion, I would hold that neither autonomy nor care ethics approaches are clear 
concepts that should be used as foundational concepts of bioethics. Rather, they capture 
certain aspects that may better be translated into the language of moral agency and 
responsibility. One of the most challenging questions bioethics has yet to solve is how agency 
and responsibility can be translated into the realm of institutional respect (for agency) and 
responsibility as justice. I have suggested that further work is therefore needed in order to 
develop the complementary approach of a critical hermeneutics and normative bioethics 
based on human dignity and human rights.  
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Abstract 
My presentation will focus on the question of how care-ethicists describe justice, and to be 
more precise: justice in modern health care with special emphasis on the physician-patient 
relationship.  
In the following paper, I would like to give a short introduction to the intensified 
conflict of the physician’s professional role in modern medicine and I will argue for the 
relevance of the physician-patient relationship in the context of justice. In the next step, I will 
characterise the ethics of care as an approach of normative ethical theory. The ethics of care 
puts a special focus on relationships and the particular other (what exactly is meant by that I 
will figure out later). On the basis of this focus I will examine whether the ethics of care can 
add new aspects to the question of how to deal with problems of justice in modern health care 
with regard to the physician-patient relationship. In particular, I will take into account the 
position of Michael Slote and his recent book “The Ethics of Care and Empathy”1 where he 
states that the ethics of care are able to deal with questions of justice. Among other things that 
I cannot mention in this context, Slote suggests the distinction between personal and 
humanitarian caring in order to clarify our moral obligations to help others. To conclude this 
discussion, I will come back to the questions of what the ethics of care can contribute to the 
discussion of justice in health care and which consequences can be drawn for the physician-
patient relationship. 
 
Keywords: The ethics of care, justice, Michael Slote, physician-patient relationship	
	 	
																																																								
1  Slote 2007, p. xiii. 
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Why questions of justice and care are important for the physician-
patient relationship 
The physician-patient relationship is subject to changes, such as new technological devices, 
pharmaceutical interventions and utilization review. They redefine medical practice insofar as 
the physician is not just responsible for her patient’s health but she is also accountable for 
acting under social and economic considerations.2 As Pellegrino points out: “The physician is 
the ‘gatekeeper’ and, as such, is morally and legally responsible simultaneously to the patient, 
for providing access to health care, and to the managed care system, for limiting that access.”3 
This might lead to an “erosion” of the physician-patient relationship because it is unclear for 
the physician to which extend she has to assume these different responsibilities that can be 
regarded as mutually exclusive. As Soren Holm states: “The professional cannot at the same 
time be the agent of the patient and the agent of the system.”4 The fact remains that the 
physician combines elements of rules and norms as well as elements of care in her profession. 
She is confronted with the actual patient she wishes to take care for and the possible dilemma 
of considering the legitimate claim for adequate care by all other potential patients. Very 
often justice and care seem to be contradictory in clinical practice. 
In the following paragraph, I will consider justice not at the macro-level of our health 
care system but at the physician’s level: justice applied to the particular patient in conflict 
with the needs of all potential patients waiting for health care. Of course, my premise is that 
there is a conflict, respectively that the physician cannot always meet the demands of the 
particular patient and the demands of all other patients. So the next question will be: What 
can a care ethicist tell us about a physician’s decision on where to draw the line between his 
professional obligation for her particular patient and the acceptance of a health care system 
that is obliged to weigh up different interests? 
The Ethics of Care 
First of all, I would like to give some brief indications on what the ethics of care means and 
what kind of normative force can be exposed in contrast to “theories of justice”. Prior to Carol 
Gilligan’s “In a different voice”5 scarcely anyone had spoken of an “ethics of care”. However, 
there is a tradition of care in the ancient Rome (Seneca) with “cura” as burden or solicitude, 
as well as care in the sense of Christian agapic love, in mediaeval literature, as well as in 
Kierkegaard’s and Heidegger’s writings6. What made Gilligan’s book so special was her 
intention to show that boys and girls apply different moral themes and concepts when they 
resolve moral dilemmas. In her psychological study about the moral development of boys and 
girls she figured out that girls tend to argue in terms of personal attachment. However, boys 
stress the equality of individuals. In general, Gilligan stated that girls more often adopt the 
care perspective as their “moral voice” whereas boys make use of the so-called justice 
perspective. A heated debate about the relevance of Gilligan’s thesis for the nature of morality 
																																																								
2  Whereas the insight of the necessity of “rationalisation and rationing” in health care is widely accepted, the 
right way of implementation is controversially discussed in bioethics. 
3  Pellegrino 1994, p. 312. 
4  Holm 2011, p. 96. 
5  Gilligan 1982. 
6 Reich and Jecker 2004. 
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and the consequences for moral theory, especially in regard to gender issues, arose. For this 
paper it is important to mention that Gilligan’s “In a different voice” encouraged philosophers 
to reconsider aspects of moral judgment such as context-sensitivity, particularity and relations 
as important. This philosophical discussion is nowadays subsumed under the topic of the 
ethics of care. 
Nevertheless, the ethics of care is also criticized for not being a fully developed ethic 
or for the possibility that the core concept of the ethics of care, namely caring, can lead to 
neglect oneself as it may lead to burdensome responsibilities. However, one of the main 
arguments against the ethics of care is that it cannot be extended to the institutional and to the 
social-political level and remains a “touchy-feely” approach. Let me explain what I exactly 
mean by that. 
The ethics of care is one perspective amongst others in ethics that focuses on the 
moral evaluation of actions based on the relation between two persons and the human 
capacity to respond to the needs of others. That is why care can be defined as an attitude 
towards others as well as a morally relevant practice7. It is relevant practice as well as an 
inner obligation to be aware of other person’s problems. Obviously, as the ethics of care 
concentrates on human relations and people’s attitudes and motives of action, it highlights the 
uniqueness of a situation. Acting in the right way is tied to a person’s internal state rather than 
to social norms or to an evaluation of consequences.8 Therefore, one might say that an ethics 
of care is concerned with the subjective issues of a moral dilemma, while justice - in the same 
situation - deals with the question of how to avoid objective unfairness. Or to quote Yuval 
Livnat: “While benevolence as a central, but also controversial, aspect in the ethics of care is 
a purely other-regarding virtue, justice is all-regarding.”9 So it seems plausible that justice-
based theories, not an ethics of care, can contribute to the discourse of a cooperative social 
coexistence. What matters is impartiality that takes everyone’s interest into account in order 
to establish rules and principles and independent reasoning to ensure that decisions are not 
made out of bare prejudice. Care is often merely seen as a supplementation to any theory of 
justice. This is due to its adherence to the individual human relations instead of generating 
universal principles. Nel Noddings, as a care ethicist that sharply distinguishes between a care 
orientation and a justice and right-based orientation respectively, does not consider this as a 
problem. By attributing “care” a moral superiority to justice orientation, she warns of the 
consequences a rule-based ethics could have: “Rules are formulated and the characteristic 
variation in response to the needs of the cared-for may fade away. Those entrusted with caring 
may focus on satisfying the formulated requirements for caretaking and fail to be present in 
their interactions with the cared-for. Thus, caring disappears and only its illusion remains.”10 
The idea of balancing in Slote’s theory 
If it is central to the ethics of care to consider the particular other as well as his needs and 
interests, then the question arises of how to treat people one barely knows. Michael Slote is 
arguing for an ethics of care that can establish a plausible view on justice on its own. In his 
book “The Ethics of Care and Empathy” he suggests a definition of the ethics of care that 
																																																								
7  Conradi 2001. 
8  This does not mean that care ethicist do not additionally want to evaluate the results of an action.  
9  Livnat 2003, p. 508). 
10  Noddings 1986, p. 25-26. 
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“treats acts as right or wrong, depending on whether they exhibit a caring or uncaring 
attitude/motivation on the part of the agent”11. As for all care ethicists, the motives and the 
state of a person’s character as well as her relations to others are fundamental to the moral 
judgment. Unlike authors of an ethics of care as Virginia Held he does not additionally 
evaluate the results of actions for effectiveness 12. However, he admits that one has to attempt 
to produce good consequences 13. Furthermore, principles or other assertions, e.g. about the 
good life, are construed as a derivative form of caring motives. If it is important for morality 
to have a caring relation based on empathy and - in fact - we cannot be intimate or even 
acquainted with every human being whose actions are morally significant for us, something 
should be said about our moral obligations towards strangers. Do we even have moral 
obligations towards them? Slote argues that we do have, however, in contrast to an utilitarian 
like Peter Singer he rejects the idea that the moral obligations towards strangers are as 
morally relevant as the obligation to help those who are close and well-known to us14. 
First of all, all human beings are equipped with self-concern or an obligation to 
develop ourselves, which prevents us from phenomena such as burnout. Offering care is a 
demanding task - in physical as well as in emotional regard - and to care appropriately 
presupposes not to care in an exhausting and self-rejecting way. However, the other 
possibility of a selfish self-concern seems to be eliminated by Slote, too. He argues that 
“someone whose concern for self is counterbalanced by genuine concern for others isn’t 
selfish”15. 
Secondly, Slote emphasizes the care for one’s intimates. We have a special and 
stronger obligation towards our family members, friends and life-partners than for people who 
are distant to us16. This obligation is a “separate moral category”17 in contrast to the broad 
concern for those one does not know. The well-known example by Bernard Williams shows 
that this conception is quite intuitive. A man who is confronted with a choice between saving 
his drowning wife and saving a drowning stranger decides to save his wife. Thus, sometimes 
it is better to act from feeling than to act from a moral principle that may lead to “one thought 
too many”18 and may hinder the rescue of both.19 
Nonetheless, acts that demonstrate empathic concern for near and dear count as wrong 
if they show a lack of empathic concern for people we don’t know. Slote is using the 
following example to illustrate this: Refusing to save a drowning child one has never seen 
before in order not to disappoint one’s daughter by being absent when she returns home from 
school seems to be wrong. This is not morally wrong because of realising a need and than 
deducing the obligation to help the drowning child. It is rather a question of whether there is 
“a problem that we perceive and/or that affects us right now”20. The immediate empathy with 
the drowning child is what makes us acting morally. 
																																																								
11  Slote 2007, p. 21. 
12  Held 2011. 
13  Slote 1998, p. 32. 
14  Slote 2007, p. 21. 
15  Slote 1998, p. 30. 
16  Slote 2007, p. 116-121. 
17  Slote 1998, p. 28. 
18  Williams 1981, p. 18. 
19  But unlike Williams, Slote has taken this case as a paradigmatic instead of an exceptional case of morality. 
20  Slote 2007, p. 27. 
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In cases of contradicting claims on the moral self, Slote is introducing the idea of 
balancing. To ensure that one does not “get swamped in the huge sea of all the other interests 
of humanity”21, self-concern should be balanced against concern for others considered as a 
class. Thus, it is easier to consider one’s intimates because they will be treated as individuals 
whereas the concerns and interests of others are cumulated. Concerns about oneself and one’s 
family will not be automatically outweighed by considerations involving larger groups. Slote 
gives two more specifications of how to conceive this balance. He distinguishes between the 
depth of concern or caring and the breadth of concern or caring22. Love is in some sense 
deeper than mere sympathy or humane concern. However, unfortunately, how exactly we 
have to understand the process of balancing remains quite unclear. For example, what is the 
right balancing of caring between our intimates –parents, children, spouse, brother, sister, 
friends, and loved ones? Are there substantial things we should care for that cannot be 
balanced? 
For Slote, this question remains already vague concerning our moral obligation 
towards strangers: “So we have moral obligations to help strangers and people we only know 
about, but I propose at this point to remain somewhat vague about just how strong these 
obligations are.”23 Slote further mentions that it is not about (approximate) equality in the idea 
of balancing, but „non-lopsidedness between concerns“24. 
He seems to assume that our moral intuitions and the capacity for empathy suffice to 
decide which actions are wrong or right and lead to situations where people in general are 
better off 25. With emphasizing the influence of intuitions for moral evaluations, he supports 
subjective grounds for moral reasoning. The problem here is that he does not scrutinize how 
this empathy (as a basis for moral judgments) is going to be transferred into a positive form 
and avoids purely naive and counterproductive forms for the individual and for society. He 
seems to assume that empathy is sufficient for avoiding discriminatory attitudes by 
experiencing another person’s situation as if one thinks in somebody’s shoes. Further, Slote 
concedes that children with a normal capacity for empathy develop habitual associations that 
„underlie and power (the use of) moral principles or rules“26. It is an intricate problem to 
argue with Slote’s theory how (wrong) attitudes of persons can be changed, because any 
normativity seems to be tied to „uncritical intuitionism“27in terms of empathy. 
For now, it is important to keep in mind that Slote argues for an ethic, that caring for 
intimates is more plausible and of stronger obligation than caring for others. According to 
psychology literature Slote is referring to, he states: 
„Agents are more empathic and empathically concerned with what they perceive than 
with what they don‘t; and they are also empathically more sensitive to what they know to be 
going on at the same time as their decision making and choices.“28 One might comment on 
this empirical findings that they do not tell us anything about moral norms; that we cannot 
																																																								
21  Slote 1998, p. 179. 
22  Slote 1998, p. 180. 
23  Slote 2007, p. 33. 
24  Slote 1998, p. 180. 
25  According to Slote, to make people better of is the moral quality in the ethics of care (and not sustaining 
caring relationships). Slote (2007). The Ethics of Care and Empathy. New York, Routledge, p. 119. 
26  Slote 2007, p. 15. 
27  van Hooft 2011, p. 151. 
28  Slote 2007, p. 43. 
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judge from is to ought or that opinions like that confuse “actions or decisions that have moral 
significance with moral judgments” 29  like John Harris is warning. For Slote, empathic 
reactions correlate with moral judgments, motives for action have justificatory power. 
Empathy can be strengthened by connections among family members, friends and life-
partners and temporal and perceptual immediacy. Thereby it also strengthens the concern for 
distant others30. Though Slote does not elaborate the exact connection between intuitive 
empathy and the normative substance of that empathic concern. Are actions wrong because 
they show a lack of empathy in the agent or do they show a lack of empathy in the agent 
because the actions are wrong? For Slote, it is rather a question of what our near and dear and 
affected people of an action perceive us in that situation – caring or uncaring – than which 
action might be right or wrong. In this sense Slote’s approach is not action-guiding, but more 
a post-hoc evaluation of performed actions31 that can strengthen the attentiveness for acting 
morally right in the future. The level of objectivity, that is important for any moral theory, is 
introduced by the moral reasoning of others and not by the caring agent himself.  
But what can Slote’s position imply for the topic of this paper? How can we describe 
the physician-patient-relationship by the care approach of Slote? 
Implications for medical practice 
At the first glance, Slote’s point of view shows that it is more important to be attentive to the 
particular patient than to restrict for example medical treatment because of potential patients 
who could benefit more of this treatment. This means not that the interests of the potential 
patients will not be considered by the physician. However, as far as I understand Slote, the 
interests of potential patients cannot outweigh the dependence of the particular patient face to 
face with the physician. The patient may probably not be an intimate of the physician. 
However, there is the direct and actual perception of the other’s need, the patient. All 
obligations that exceed this direct answer to need, are called a supererogatory act by Slote32. 
Thus, doing something for distant people is praiseworthy. However, it is neither a moral 
requirement nor the duty of the moral agent or - in our case the physician. According to Slote, 
a more than „fully developed empathy“ is necessary for supererogatory acts. For ordinary 
people, it is not expected to go beyond their moral duty33. Nonetheless, he insists on the fact 
that caring acts for near and dear count as wrong “if at the same time they show a lack of 
normally or fully developed empathic concern for people we don’t know”34. 
In medicine, the term care carries great weight. Some forms of cure derive from caring. 
It is not only the physician’s technical knowledge that helps restoring health, but also a kind 
of personal attentiveness to both: the physical and the emotional components of illness. The 
physician should offer the most possible appreciation of the patient’s values and concerns as 
well as support for the particular patient. Of course, patient autonomy in the sense of self-
																																																								
29  Harris 2012, p. 297. 
30  Slote 2007, p. 28. 
31  White 2009. 
32  Slote 2007, p. 34. 
33  Supererogation is defined here as going beyond moral duty. Other definitions of supererogation, such as 
“having greater merit” and “morally good but not required, with no implication either of superior merit or 
of going beyond duty” is introduced by Lawrence Blum Blum (1988). "Gilligan and Kohlberg. Implications 
for Moral Theory." Ethics 98(3): 472-491, p. 489-490. 
34  Slote 2007, p. 31. 
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determination is enforced in the last decades, however, the physician has a special 
responsibility towards his patient. Physicians are still translators of medical information to 
their patients, they give recommendations and they remain the experts for definitions of 
disease. The core concept of a physician’s responsibility for the patient - as it is described in 
the Hippocratic oath: “And I will use regimens for the benefit of the ill in accordance with my 
ability and my judgment, but from what is to their harm or injustice I will keep them”35. This 
responsibility is going to shift away from physician expertise to organizational efficiency as 
requirements like “rationing” find one’s way into everyday medical practice36 However, what 
could a care ethicist like Slote respond to this development in modern medicine?  
Slote does not cease to say that empathic concern is merely something to be located at 
the level of personal relationships. He rather suggests to transfer the concept of empathic 
concern to social practices and institutions. 
„So an ethics of empathic caring can say that institutions and laws, as well as social 
customs and practices, are just if they reflect empathically caring motivation on the part of 
(enough of) those responsible for originating and maintaining them.“37  
In accordance with the paper’s topic, one can argue with Slote that questions like 
justice in modern health care are questions of the stakeholders’ right motives as their actions 
are judged by expressed or reflective motives. These motives should be based on empathy and 
concern for patients’ needs, at least stakeholders should not exhibit a lack of empathic 
concern38. The advantage of Slote’s opinion is the strengthening of the right motives for an 
action and the question of which actions express a “fully developed empathic concern”. It is 
not the important here that he offers a model of how to exactly balance the interests of the 
market or all other patients waiting for care, the particular patient and the physician’s 
responsibility. It is rather a reminder of what really should be the focus of interest in medicine 
while talking about justice in medicine: it is the particular patient and his need. Or like 
Virginia Held states: 
“With the ethics of care and an understanding of its intertwined values, such as those 
of sensitivity, empathy, responsiveness, and taking responsibility, we could perhaps more 
adequately judge where the boundaries of the market should be.”39 
Conclusions 
Now let me come to my conclusions. At the first glance, Slote offers an attractive approach of 
how to deal with the question of justice in modern health care. However, his differentiation in 
personal and humanitarian care lacks fundamental considerations because it remains quite 
vague about how to balance these two aspects of care, its function is not action-guiding. 
Nevertheless, it offers an opportunity to reflect the possibility that – when it comes to 
questions of justice – it is often not just the outcome of an action or the rights of individuals 
that are expressed by these actions, but also the motivation and the attitude of the agent that 
may count. 
																																																								
35  Miles 2004, p. xiii. 
36  Pellegrino 1994. 
37  (Slote 2007, S. 94). 
38  (Slote 2007, S. 95). 
39  (Held 2006, S. 119). 
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A last point I would like to take into consideration is the following: Slote’s position of 
care is not taken up by the major part of care ethicists. What I exactly mean is that if we 
favour someone who is our intimate, this attitude does not exhibit particular virtuous motives 
or dispositions, because it seems to be too self-centered. Quite the contrary is the case, caring 
for others - including strangers - is expressing apparently more caring motives than just 
promoting the relations to our loved ones. Caring should also involve people that are not right 
next to us and do not emotionally affect us. This point is applied by Slote when he is talking 
about humanitarian caring. However, he does not underline that caring for strangers may also 
be a strong moral obligation. In my opinion, the ethics of care should consider the claim for 
caring for others – in the sense of caring for and about strangers – more detailed to guarantee 
an ethics that is suitable for all moral questions, especially for questions of justice. 
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Abstract 
The unprecedented development in the fields of biomedicine and the diffusion of 
sophisticated technologies has led to a rethinking of medical practice. In particular, human 
enhancement makes this re-examination urgent because in general it refers to enhancing 
healthy human beings with medical means to improve their abilities and traits. In other words, 
through human enhancement there is an application of medical knowledge and technologies 
to issues that are not originally thought as medical ones: medicine is not simply used to 
overcome biological pathologies, but to actually improve human capacities. Nevertheless, it 
would be wrong to exclusively explore this aspect within the conversation about the proper 
aims of medical practice, neglecting the purposes of society. Indeed, medicine does not exist 
in isolation and it must be in dialogue with the society it serves. 
If that is true, what kind of relationship can be established between the proper aims of 
medicine and the purposes of society? Is there any order of priority? Should medicine be 
constantly redefined on the basis of social needs/desires? 
To discuss these issues, the paper will be developed in three stages: first, by focusing 
on the therapy/enhancement distinction and its limitations; second, by referring to the 
ends/goals of medicine distinction proposed by Edmund D. Pellegrino; third, by analysing the 
latter distinction as regards the debate on human enhancement. 
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Introduction 
Although medicine has been changing continuously throughout history, the unprecedented 
development in the fields of biomedicine and the diffusion of sophisticated technologies have 
led to a rethinking of medical practice. In particular, human enhancement makes this re-
examination urgent because in general it refers to enhancing healthy human beings with 
medical means to improve their abilities and traits. As a matter of fact, a wide variety of 
promising biotechnologies may increase our possibility of enhancing human performance, for 
example avoiding memory loss, altering our mood, and slowing senescence. Also, the 
development of reproductive technologies (genetic screening and genetic engineering) could 
be used to insert genes that are not present in the gene pool or to alter the so-called non-
disease genes, genes that do not cause a genetic disorder or do not predispose one to the 
development of disease. While at the present the tools of genetics, such as vitro fertilization 
(IVF) and preimplantation genetic diagnosis (PGD), allow us to test the embryos for disease 
traits and to select offspring on the basis of this information, in the future these technologies 
might be used to test for non-disease traits, such as intelligence and memory. Thus, it might 
be possible to select the child with the best intelligence or memory profile. 
We already have powers to alter our capacities, for example with the use of stimulants 
or psychoactive drugs; nevertheless, if the use of biotechnical powers has mainly been 
indicated to heal the sick and relieve the suffering, the attractive biomedical technologies 
could serve purposes that go “beyond therapy” [1]. For example, techniques for boosting 
muscle strength could be used not only to treat muscular dystrophy but also to enable athletes 
to attain a superior performance. A central nervous system stimulant as Ritalin, prescribed for 
the treatment of attention deficit hyperactivity disorder (ADHD), might be utilized by 
untreated ADHD students to enhance their cognitive performance. 
In other words, through human enhancement there is an application of medical 
knowledge and technologies on issues that were not originally thought of as medical ones: 
medicine is not simply used to overcome biological pathologies (restitutio ad integrum), but 
to actually improve human capacities (transformatio ad optimum) [2]. Nevertheless, it would 
be wrong to exclusively explore this aspect within the conversation about the proper aims of 
medical practice, neglecting the purposes of society. Medicine does not exist in isolation and 
it must be in dialogue with the society it serves. This means that reflecting on medicine and its 
aims needs to take the social frame within which medical practice comes to fruition into 
account. 
If this is true, what kind of relationship can be established between the proper aims of 
medicine and the purposes of society? Is there any order of priority? Should medicine be 
constantly redefined on the basis of social needs/desires? 
To discuss these issues, the presentation will be developed in three stages: first, by 
focusing on the therapy/enhancement distinction and its limitations; second, by referring to 
the ends/goals of medicine distinction proposed by Edmund D. Pellegrino; third, by analyzing 
the latter distinction as regards the debate on human enhancement. 
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The therapy/enhancement distinction 
The distinction between therapy and enhancement is often introduced in discussions regarding 
the status of medicine to specify what falls within and outside medical practice, 
circumscribing its tasks and activities. From this point of view, “therapy” is the use of 
biomedical power to treat diseases or disabilities and relieve suffering, and “enhancement” 
refers to any biotechnical interventions that alter non-disease processes to improve human 
performances. Through this approach, an enhancing intervention is therefore understood and 
described as contrary to a medical treatment: while the latter addresses the health problems 
created by diseases, the former refers to any improvement in human abilities and normal traits 
that do not respond to legitimate medical needs. 
At first glance, making such a distinction between therapy and enhancement could be 
basically useful for two reasons; on the one hand, it might help to determine the role of 
medicine and the physicians’ duties, defining the boundaries of medical practice and 
specifying what doctors should or should not do. On the other hand, the therapy/enhancement 
distinction might contribute to defining a basic package care, delineating precisely what 
services systems of health care should and should not reimburse. Therefore, if such a 
distinction is correct, it has practical and normative relevance because it circumscribes the 
medical activities and it distinguishes the ethically acceptable uses of biomedical technologies 
(therapeutic treatments) from the ethically unacceptable or dubious ones (enhancing 
interventions). 
Although it could offer these advantages, the therapy/enhancement distinction is 
inaccurate and highly problematical given the difficulties to justify it both on a theoretical 
level and a practical one. Firstly, it is not easy to define what “therapy” and “enhancement” 
mean because these notions refer to other complex and controversial concepts, such as 
“health”, “disease”, and “normality”. If the therapy/enhancement distinction relies on these 
notions, the following questions come to the forefront: exactly what does being “healthy”, 
“normal” mean? How can we define a “normal healthy state”? Given the complexity 
connected to any attempt to draw a specific line between “health” and “disease”, the 
therapy/enhancement distinction can be criticized on its theoretical grounds. Secondly, this 
distinction seems troublesome at a practical level as well because interventions that are 
originally developed for therapeutic goals could later count as enhancements. Indeed, 
“therapy” and “enhancement” are overlapping categories given that successful therapeutic 
treatments are enhancing interventions too. Also, how should prevention activities be 
considered? Are they treatments or enhancements or something else? As a matter of fact, 
preventative therapeutic interventions strengthen the body’s abilities and functions, and 
reduce the probability of disease and death. Consequently, these interventions seem to be 
enhancement. 
In light of all these conceptual and practical problems, does it still make sense to refer 
to this vague distinction? As argued by Erik Parens: 
It would be a mistake to think that the therapy/enhancement distinction will ever 
provide good, transparent moral guidance about the particular decisions faced by 
individuals such as doctors or institutions such as managed care companies [3, p. 24]. 
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However, despite its several limitations, this distinction could help to begin, and not to end, a 
conversation about medicine. Quoting Parens: 
There is a big difference between hoping that a given distinction can begin 
conversation, and thinking it can end one [3, p. 10]. 
After the several difficulties connected to the therapy/enhancement distinction are 
recognized, it may then be used as one way to begin conversations about medical practice and 
its aims. In this way, further considerations related to the status of medicine could be 
developed in light of its contemporary possibilities. Indeed, traditional definitions of medicine 
that describe it as a human activity simply aimed to treat diseases or disabilities and to 
maintain a healthy state do not capture the complexity of modern scientific medicine and its 
several practical dimensions. Besides the role of contemporary medicine in the prevention and 
treatment of diseases, there are other uses of biomedical power to satisfy individual desires 
(for example requests for cosmetic surgery motivated by a desire for beauty) and to expand 
human choice and possibility (for example with the use of reproductive technologies in order 
to “design” babies or improve their native equipment). 
Taking all these purposes of medicine into consideration, is there any differentiation 
among them? Should they be examined in the same way or could any order of priority be 
suggested? 
Regarding the nature of medicine and its goals, two main approaches have been 
offered in the bioethics debate: the inherentist position and the social construction view. The 
former is grounded on the nature of medicine and holds that the ends of medical practice grow 
out of the universal human experience of illness. Indeed, this approach defines the ends of 
medicine from the permanent phenomena of the clinical encounter and considers care, cure 
and healing as what makes medical practice what it is. These ends distinguish medicine from 
other human activities and give it a fixed essence. On the contrary, moving from the great 
variation of the nature and the goals of medicine throughout its history, the social construction 
view rejects that there is something permanent about medicine; as a consequence, this 
approach affirms that the goals or purposes of medicine have to be continually redefined by 
each social community it serves. 
Published in 1996 and gained from a research project initiated in 1993 and 
coordinated by Daniel Callahan, The Hasting Center Report on The Goals of Medicine. 
Setting New Priorities faces both the advantages of these two approaches of the derivation of 
the goals of medicine and the deep opposition between them1. The Report then suggests “a 
reasonable middle ground”: 
Medicine has essential ends, shaped by more or less universal ideals and kinds of 
historical practices, but its knowledge and skills also lend themselves to a significant 
                                                 
1  This Report provides an analysis of contemporary medicine, focusing on its aims as well as its new and 
varied potentialities. The opening pages take into account the several reasons (identified as “new 
pressures”) that make a reexamination of the goals of medicine particularly urgent, and the topic of human 
enhancement is one of them (the other reasons are: the scientific and technological developments, balancing 
the curative bias, aging populations, the market and public demands, cultural pressures, and the 
medicalization of life) [4, pp. 6-12]. 
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degree of social construction. It is a reduction of the former to the latter that is the real 
danger, not holding both in a fruitful tension with each other [4, p. 17]. 
Although The Hasting Center Report recognizes the need for a dialogue between 
medicine and society, it does not establish any order of priority between the purposes of 
medicine defined by its historical practices and those shaped by social construction. Also, 
affirming that a certain tension among these aims is fruitful, it does not suggest any solution 
when they are in conflict. 
In my opinion, Edmund Pellegrino (Chairman of The President’s Council on Bioethics 
from 2005 to 2009) provides further important considerations to the middle ground approach 
provided by the Hasting Center Report. Defending what he prefers to call an “essentialist 
approach”, Pellegrino introduces a distinction within the several aims of medical practice: the 
ends/goals of medicine distinction. Furthermore, he suggests a certain kind of relationship 
between the ends and the goals of medicine that could be useful in the debate on human 
enhancement. 
The ends/goals of medicine distinction 
In order to analyze the nature of medicine and to grasp what makes it a different enterprise 
compared to other human activities, Pellegrino proposes a phenomenological and teleological 
approach to the clinical encounter. Seeking a foundation for medical morality independent of 
any previous philosophical theories, this approach is based on the analysis of the three 
phenomena specific to medicine: the fact of illness, the act of profession, and the act of 
medicine. For Pellegrino, the universal human experience of illness and the resulting need of 
sick people for care, cure, and healing give medicine its essential character. These aspects 
distinguish medical practice from other human activities and permit its permanence. Indeed, 
medicine comes into being because people get sick; quoting Pellegrino, “medicine and 
physicians exist because humans become ill” [5, p. 27]. 
When illness occurs, a human being perceives an altered state of his existence because 
he detects some changes in the functions of his body or his mind and considers himself no 
longer “healthy” (understood here as a fluid and multi interpretable word), no longer “whole”. 
The person who is ill lives an existence characterized by anxiety, and this is basically due to 
these two reasons: on the one hand, he does not know the causes of that altered state of his 
existence and he lacks the knowledge and the skills necessary to cure himself; on the other 
hand, he cannot be sure he will be “healthy”, “whole” again. Also, a particular vulnerable 
state derives from illness because human freedoms are compromised, alterations in lifestyle 
are imposed, and the images of the self and the body are subjected to relevant changes. 
Because of illness the body stands opposite to the self and is no longer an instrument of our 
will, impeding our choices and actions. For all these reasons, Pellegrino affirms that 
the state of being ill is […] a state of “wounded humanity” of a person compromised in 
his fundamental capacity to deal with his vulnerability [5, p. 28]. 
The author describes illness as an ontological assault on the humanity of the person 
because it erodes the body-self unity and forces a rethinking of human existence and a 
reappraisal of life plans. 
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From Pellegrino’s point of view, being ill means being forced to seek assistance, 
whether voluntarily or not, from another person, i.e. the health professional, determining a 
need for healing, a need for the patient-physician relationship. 
Becoming a patient, someone who is ill has to place himself under the power of 
another person, who professes to have the necessary knowledge and skills to heal. As 
emphasized by Pellegrino, this aspect is confirmed by the etymology of the word “profession” 
because it derives from the Latin verb profiteri, which means “to declare aloud or publicly”; 
concerning the health professional 
he/she “declares aloud” that he has special knowledge and skills, that he can heal, or 
help, and that he will do so in the patient’s interest, not his own [5, p. 29]. 
Determined by the fact of illness, the patient-physician relationship is always 
described in terms of an inequality of knowledge and skills because it is established between 
an existentially vulnerable person seeking assistance and another one who professes to 
provide it. Given this not eliminable inequality, the patient-physician relationship cannot be 
simply regarded as a contract between equals because the professional holds the balance of 
power and the patient is therefore forced to trust him. 
From Pellegrino’s point of view, another phenomenon that characterizes medical 
practice is “the act of medicine”, which is the specific action that identifies that profession. 
Medicine is actually realized when a clinical decision is made and “a right and good healing 
action” [5, p. 30] takes place; these aspects bring together the physician’s knowledge and 
skills and the patient’s need to be healed, and constitute medicine qua medicine. Quoting 
Pellegrino, 
this central act is the vehicle of authenticity and the bridge which joins the need of the 
one seeking help with the promise of the one professing to help. […] It is a choice of 
what is right in the sense of what conforms scientifically, logically, and technically to 
the patient’s needs and a choice of what is good, what is “worthwhile” for this patient 
[5, p. 30]. 
Accordingly, the therapeutic action can be individualized through a shared inquiry 
because it needs the physician’s competence to be technically correct and the patient’s agency 
to respect his values. For Pellegrino, the act of medicine is the end of the clinical encounter 
because in this special kind of human interaction, physician and patient work together for the 
same task of healing. As already noted, someone who is ill needs to be healed and the health 
professional responds to this need, and therefore the fiduciary relationship aims to the same 
end: the patient’s good. 
To sum up, the fact of illness, the act of profession, and the act of medicine are the 
essential features of medicine qua medicine because they characterize medical practice 
whenever and wherever it takes place. Being mortal, humans become ill, need help, and are 
forced to seek assistance from those who profess to be healers. The consequent clinical 
encounter reveals its teleological structure because it aims to a specific end, i.e. a right and 
good healing action, shared by the subjects involved in that particular relationship. 
Within this phenomenological and teleological approach care, cure and healing are 
the ends of medicine: in the classical sense of telos, ends are essentially defined and 
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ontologically related to the nature of medicine. Ends are the essence of medicine and they 
serve to define medical enterprise; as just noted, they are discerned by reflecting on the 
patient-physician relationship, that is on the peculiar relationship of healing and helping that 
has always been typical of medical practice and will always be in the future. Therefore, these 
ends are permanent and intrinsic to medicine and they characterize medical enterprise 
whenever and wherever it takes place. 
Although the phenomenological and teleological approach proposed by Pellegrino is 
particularly focused on the clinical encounter, it does not imply an exclusion of the social 
context. Indeed, apart from the ends, his essentialist model acknowledges the presence of the 
goals of medicine [6]; by introducing this expression, Pellegrino refers to what society may 
wish to attain through biomedical power for uses other than care, cure, and healing. For 
example, the use of medical knowledge could be influenced by cultural and social pressures 
and used for nonmedical purposes to satisfy human desires and to attain economic or political 
advantages. Given that goals are externally defined and not built into the nature of medicine 
itself, they may or may not conform to the ends of medicine [6, p. 59]. Indeed, the goals are 
not necessarily tied to the essence of medical enterprise; this means that they are subject to 
many interpretations and they may be altered by individuals, societies, or governments. 
In Pellegrino's opinion, a relationship between the ends and the goals of medicine 
must be established because medical practice comes to fruition within a particular social 
context. As a consequence, a dialogue between medicine and society must be encouraged [6, 
p. 65]. Also, in order to meet health care institutions’ needs as well as social needs a certain 
kind of modification within the medical field is possible and inevitable. For example, 
although medicine advances the healing, caring and curing ends, a just distribution of health 
care resources must be advocated on the basis of their availability. Nevertheless, for 
Pellegrino, the goals of medicine cannot completely replace the ends of care, cure and 
healing because this change compromises the integrity of medicine itself [6, p. 65]. If such a 
transformation occurs, medicine may be used exclusively to advance economic or political 
purposes, or subdued to social ideology. As a result, the nature of that peculiar human activity 
that arises from the universal human experience of illness and the resulting need for healing 
could be deeply compromised. 
Therefore, the ends have priority over the goals of medicine and, differently from 
what has been suggested by The Hasting Center Report, Pellegrino’s approach establishes an 
order of priority among the several aims of medicine and provides a basic criterion to deal 
with conflict situations. 
A constant critical reflection on the goals of medicine is thus required to verify if they 
are distorting or impairing the capacity of medicine to achieve its proper ends. In order to 
ensure that the goals of medicine conform to the ends, Pellegrino suggests a careful analysis 
of the clinical encounter and its teleological structure: by examining this peculiar human 
interaction, the essence of medical enterprise can be gathered and what may enhance the ends 
of medicine can be encouraged. 
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Some possible practical implications 
In light of the unprecedented development in the fields of biomedicine and the diffusion of 
sophisticated technologies, the essentialist approach proposed by Pellegrino could be useful, 
basically for two reasons: on the one hand, it defines the ends of medicine and specifies the 
reasons for preserving them; on the other hand, it allows for a certain kind of modification 
within medical practice by recognizing the presence of the goals of medicine. Therefore, this 
theoretical model encourages a dialogue between medicine and society, but it asserts that 
economic, political or ideological pressures cannot distort the intrinsic ends of medicine. 
In particular, regarding the topic of human enhancement, the ends/goals of medicine 
distinction reminds us that a complete application of medical knowledge and technologies to 
enhance healthy human beings is problematical because it modifies that human activity which 
is essentially oriented towards providing care and cure to sick people. As pointed out by 
Pellegrino, if this radical transformation of medicine was to occur and enhancement was to be 
considered an end of medicine, the term “patient” would be extended to anyone unhappy with 
his abilities or traits and the process of medicalization would influence all aspects of human 
existence [7]. Furthermore, several consequences would characterize the medical enterprise 
and its practical dimensions. Quoting Pellegrino: 
The number of physicians needed would skyrocket; access by those with disease states 
would be compromised; research and development could become even more 
commercialized and industrialized. Research resources would be channeled away from 
therapy per se. The gap in access to therapy between those able to pay for doctor’s time 
and those who cannot would expand. To make physicians into enhancement therapists is 
to make therapy a happiness nostrum, not a true healing enterprise [7]. 
Here we face the therapy/enhancement distinction again and, to those who criticize it, 
Pellegrino replies that medical treatments could be described as enhancement interventions 
because as often as not they make patients feel better, regaining their functional capacity. 
Nevertheless, 
this kind of enhancement follows therapy and is part of the aim of therapy – not 
“beyond” therapy but a result of it. This is different from enhancement as a primary 
intention. Here we start with someone who has no disease or obvious bodily 
malformation [7]. 
Related to the proper ends of medicine, the therapy/enhancement distinction is thus 
still useful and it may be helpful to distinguish the different medical uses of biotechnological 
advancements. Therefore, when enhancement becomes a primary purpose of the use of 
biomedical power, this goal does not adhere to the intrinsic ends of medicine. Indeed, thus 
intended, enhancement interventions aim to improve abilities and traits of healthy human 
beings whereas medicine arises from the universal human experience of illness and the 
resulting need for healing. As an end in itself, enhancement threatens the integrity of medicine 
and its essence, increases the physician’s responsibilities and finally, compromises the access 
for those who need healing. For all these reasons Pellegrino asserts that 
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preserving the ends of medicine, and not just the goals society may construct for 
medicine, is an essential safeguard not simply for the integrity of medical ethics and 
practice, but for the safety and wellbeing of all the vulnerable members of our society 
[6, p. 67]. 
Therefore, what is at stake here is not simply the status of medicine, but rather the 
safeguard for the vulnerability of the human being and his ineliminable finitude: being mortal, 
humans become ill and vulnerable, need help, and are forced to seek assistance from those 
who profess to be healers. 
In my opinion, all these aspects should be taken into account to continue a dialectic 
and fruitful relationship between medicine and society. In this way, medical enterprise will 
persist in helping sick people, and, at the same time, it will be open to respond to social 
requirements by verifying their conformity to its ends of care, cure and healing. 
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Abstract 
From the title of the conference I’d like to call my essay The quest for a perfect death. 
Thoughts on death and dying in the future. I’ve divided my text into three parts: In the first 
almost descriptive and hermeneutical part I give some insights into present social 
developments concerning death and dying in our high income societies. Inspired by the 
guiding questions in the program of the Conference I sketch two extreme future scenarios in 
the second part: the assisted suicide scenario and the “palliative care” scenario. As the 
labeling of the two outlines already reveals I presuppose value judgments, respectively 
assumptions, about a good and bad death without opening them up to discussion. In the third 
part I try to outline a desirable future scenario with regard to recent developments. That third 
part is normative since I draft some moral arguments concerning death and dying in the near 
future. The central idea of my vision of the future is centered on the assumption that an art of 
dying (ars moriendi) is identical to an art of living (ars vivendi). Because an over-planned life 
could end up in a state of self-blockade, we should envision the rediscovering of acceptance 
of what once was called “fate”.  
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Current Developments 
In the last twenty years death and dying have become issues of enormous public interest. 
While Elisabeth Kübler-Ross with her famous book “On death and Dying” touched a social 
taboo at the end of the nineteen-sixties [1], today death and dying have become subjects of 
ordinary and common discourses. While this change is normally traced to the popular studies 
of Elisabeth Kübler-Ross, important academic work has already been done by well known 
sociologists, as Allan Kellehear stresses in his amazing and helpful overview of death-studies 
published during the last 40 years [1]. 
There was the public dying of Pope John Paul II in 2005, the stories about Terry 
Schiavo in the US, Diane Pretty in the UK, Eluana Englaro and Piergiorgio Welby in Italy, 
Vincent Humbert and Chantal Sebire in France, Noël Martin in Germany, Gunter Sachs in 
Switzerland. These are just a few important examples, which only touch the tip of the iceberg 
of public interest for death and dying. 
To demonstrate this new interest – which indeed contradicts the often repeated and 
nevertheless false thesis of death denial in our societies – further examples are easy to find: 
We know assisted suicide and euthanasia as issues in famous films like “Mar adentro” of 
Alejandro Amenábar or Clint Eastwood’s “Million dollar baby”, there are not only cyber 
cemeteries, scientific interest in near death-experiences, but also special homepages like 
www.sterbehilfedeutschland.de bringing up daily news about death and dying, there are 
unending talk-shows with personal testimonies on dying experiences, there is the famous 
exhibition “Noch mal leben vor dem Tod” (“Live once more before death”) shown in 
Germany, Switzerland, Austria, Israel and the UK with larger than life-portraits of dying and 
dead people, there are legal, ethical, political discussions about good dying in parliaments, 
courts, scientific settings etc. Because of the emergence of new institutions like hospices, 
palliative care institutions, new professions, legal regulations like the laws on advance 
directives, euthanasia or assisted suicide makes sociologists today talk about  
 
 an institutionalization of death and dying,  
 the discovery of dying (as the Swiss sociologist Ursula Streckeisen does, referring 
to the “discovery of childhood” in the well known book “Centuries of childhood” 
written by Philippe Ariès), 
 the new visibility of death (die “Neue Sichtbarkeit des Todes”, as Thomas Macho 
and Kristin Marek do in a recent book title [2]), or even  
 the loquaciousness of death (die “Geschwätzigkeit des Todes”), as the German 
sociologist Armin Nassehi does [3],  
 
indicating processes of scientification, politicization, economization, medicalization and 
juridification of dying in our modern societies. For non sociologists the book of Reimer 
Gronemeyer called “Sterben in Deutschland“ is more readable while describing the same 
tendencies [4]. 
Nevertheless all these changes are marked by a deep ambivalence: While nearly all 
people would like to know more about dying processes, about experiences and possibilities to 
intervene or to make provisions for their own death, most of them have never had the real 
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experience with death or dying in their daily life (perhaps apart from car accidents or risky 
sports). Death and dying are happening in special institutions like nursing homes, hospitals or 
hospices. According to the German sociologist Werner Schneider these developments indicate 
a new arrangement or a re-arrangement of the last phase of life in our western societies: The 
modern idea of understanding death as “the enemy of life” is disappearing, the discourse 
doesn’t pronounce both the struggle for life and the struggle against death any more, while 
stressing new forms of social and cultural securing (“Sicherstellung“) of death and dying [5]. 
Death is no more something we have to prevent under all circumstances, but something we 
should control according to our own ideas and ideals. Apparently these developments bear 
new ideals and norms about good and bad dying (a late modern age ars moriendi, so to say): 
Central norms are doubtless self-determination, the ideal of dying as a self-controlled, 
conscious and active act, and the importance of retaining a good quality of life until the last 
hours of life. Both assisted suicide and palliative care fit in this “new” concept, although they 
are often confronted with one another: “For both, the worst evil is a poor quality of life.”[6] 
A European study published by the National Institute for Demographic Studies in 
Paris 2007 came to a similar result: “The circumstances of death have changed over the last 
hundred years in Europe. Most people die at old or very old ages, often in a hospital or care 
home after a long chronic illness. A much wider range of medical treatments and palliative 
care has also become available. Patients, for their part, more often prefer to die peacefully 
rather than prolong life at all costs.” [7] 
As the results of the EURELD-study have shown, more than 50% of all deaths in 
Switzerland are linked with medical decisions concerning the end of life [8]. If one subtracts 
deaths occurring in the streets or mountains without any possibility of medical intervention 
we have to face that in about three quarters of all deaths Medical Decisions concerning the 
End of Life of the patients (MDELs) were taken. In 28% of all deaths decisions are taken to 
withhold or withdraw treatments, and in 22% decisions about alleviation of pain and 
symptoms with possible life-shortening effects. Compared to the more controversial practices 
of killing on request (0.27%), assisted suicide (0.36%) and merci killing (0.42%), these two 
types of medical decisions concern comparatively a lot of cases.  
In his overview of the social and behavioral studies on death Allan Kellehear, 
sociologist at the University of Bath in the UK, stresses the important fact that all we know 
about dying is mainly through the lens of illness [1, p. 19]. We still know very little about 
other forms of dying, especially about poverty experiences of dying, non-illness forms of 
dying, e.g. dying in prison, by suicide or war. He also indicates that there are sharp divisions 
in the literature between a material view of dying that emphasizes social and bodily decline 
(as Sherwin Nuland outlines in his book “How we die” [9]) and other literature that examines 
unusual psychological and social experiences associated with that bodily decline (like 
deathbed visions or near death experiences [10]). 
Two future scenarios 
Inspired by the guiding questions in the program of the Conference I distinguish two extreme 
scenarios in order to work out some crucial points in a very simplistic manner. In the second 
volume of “The Principle of Hope” (first published as “Prinzip Hoffnung” in 1959), under the 
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title “Outlines of a better world”, Ernst Bloch has written a chapter on the struggle for health 
and medical utopias (chapter 35): Here he criticizes the absence of utopian thinking of 
physicians and (like Francis Bacon in the 17th century) conceives the importance of struggling 
for health and against death. He even dreamed about the abolition of death: “We may finally 
risk the proposition that precisely because the doctor, even at the individual sick-bed, has an 
almost crazy utopian plan latently in view, he ostensibly avoids it. This definitive plan, the 
final medical wishful dream, is nothing less than the abolition of death.” [11, p. 465] To reach 
that goal we have to fight against destiny. Ernst Bloch was convinced that this fight creates 
the link between medical and social utopias. 
Imagine we woke up some morning realizing that we live in the year 2050. The crazy 
utopian plan of the doctors has not yet become fully true, but efforts in medicine and public 
health have led to a situation where a lot of dangerous illnesses have been eliminated and 
human enhancement technologies have been established, so that life expectancy could be 
extended to an average of more than 200 years. Chronic diseases, psychiatric disorders, 
overpopulation and longevity are now the most important problems of mankind, at least in the 
high-income countries. 
In this situation a first scenario concerning death and dying could be an assisted 
suicide-scenario. Regarding the wording of the title I was inspired both by the actual practice 
in Switzerland and the metaphor of the last men in the Prologue of Friedrich Nietzsche’s 
Zarathustra. For Zarathustra the vision of the last men was a real “Dystopia”, but the people 
didn’t understand him (he, Friedrich Nietzsche alias Zarathustra, as the misunderstood 
prophet): 
“The earth has then become small, and on it there hops the last man who makes 
everything small. His species is ineradicable like that of the ground-flea; the last man lives 
longest. (…)  Turning ill and being distrustful, they consider sinful: they walk warily. (…) A 
little poison now and then: that makes pleasant dreams. And much poison at last for a pleasant 
death. (…) No shepherd, and one herd! Every one wants the same; every one is equal: he who 
has other sentiments goes voluntarily into the madhouse. (…) They have their little pleasures 
for the day, and their little pleasures for the night, but they have a regard for health. ‘We have 
discovered happiness’, say the last men, and blink thereby.” [12]1  
Central issues for the last men in Nietzsche’s “Book for All and None” as in my 
assisted suicide scenario are the importance of health, the abolition of illnesses, the equality 
of all in the sense of indifference and apathy, longevity and the search for happiness. In this 
society a lot of possibilities to die after most illnesses were abolished and anti-aging measures 
were widely established do not remain. For a pleasant death people will need poison. That 
brings to mind what Thomas Morus had already written in his “Utopia” in 1518: 
                                                                
1  Im deutschsprachigen Original [12, 19–20]: „Die Erde ist dann klein geworden, und auf ihr hüpft der letzte 
Mensch, der Alles klein macht. Sein Geschlecht ist unaustilgbar, wie der Erdfloh; der letzte Mensch lebt am 
längsten. (…) Krank-werden und Misstrauen-haben gilt ihnen sündhaft: man geht achtsam einher. (…) Ein 
wenig Gift ab und zu: das macht angenehme Träume. Und viel Gift zuletzt, zu einem angenehmen Sterben. 
(...) Kein Hirt und eine Herde! Jeder will das Gleiche, Jeder ist gleich: wer anders fühlt, geht freiwillig ins 
Irrenhaus. Man hat sein Lüstchen für den Tag und sein Lüstchen für die Nacht: aber man ehrt die 
Gesundheit. ‚Wir haben das Glück erfunden’, sagen die letzten Menschen und blinzeln.” 
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“I have already told you with what care they look after their sick (…); but when any is 
taken with a torturing and lingering pain, so that there is no hope either of recovery or ease, 
the priests and magistrates come and exhort them, that, since they are now unable to go on 
with the business of life, are become a burden to themselves and to all about them, and they 
have really out-lived themselves, they should no longer nourish such a rooted distemper, but 
choose rather to die since they cannot live but in much misery (…); since, by their acting thus, 
they lose none of the pleasures, but only the troubles of life, they think they behave not only 
reasonably but in a manner consistent with religion and piety; because they follow the advice 
given them by their priests, who are the expounders of the will of God.” [13, p. 83] 
These ideas also remind us of Michel Foucault’s system of bio-power as a new 
formation of power in western societies: The prerogative of the state – according to Thomas 
Morus, the priests and magistrates, in a future society perhaps public health experts or ethics 
committees – to decide on the life and death of its citizens. Besides chronic pain one major 
problem will be the state of boredom, indifference and coldness, as Bernard Williams stated 
in his often cited essay on the tedium of immortality [14]. “Everything is joyless”, he quotes 
the 342 year old Elina Makropulos, and the description of her experiences sounds like the 
feelings of the last men in Nietzsche’s Zarathustra. One major problem in these societies will 
be the isolation of their members and tiredness of life. If people do not remember their 
children because they are too old and there are too many descendants, they are isolated, 
without meaning in life and therefore ready to die by killing themselves, if there is no other 
possibility to die. In a world without “natural” death we will have the real problem with how 
and when to end the boring and indifferent life. A real dystopia! 
A second future scenario I call the “palliative care” scenario, also conceived as a 
dystopian vision. In this scenario everyone dies without pain and having found meaning in 
their death [15]. “Palliative care” is written in quotation marks because it is meant in the sense 
of an overexaggerated care which bans or eliminates all kind of personal, especially negative 
experiences, like doubts, despair, hopelessness or unbearable suffering: Everybody is able to 
find meaning not only in pain, but also in suffering, dependence on others, finitude of life, 
death and dying. If someone doesn’t find a meaning, he or she has a problem which could be 
resolved with the help of professional care of social workers, psychologists, physicians, 
nurses or priests. The central idea is what Cicely Saunders once called total patient care. 
There are structures of all-embracing care with area-covering provision of hospices and 
palliative care teams, and a standardization of dying processes, as Stefan Dresske describes in 
his ethnographic studies made in German hospices today [16]. If someone gets too old and 
doesn’t want to live anymore, there are socially accepted ways of reducing eating and 
drinking without feeling pain or suffering until death. Everybody writes advanced directives 
to assure self-determination. The fight against fate is an important task, the quality of life to 
the last breath the central ideal, where everyone defines for themselves what quality means. 
Quality-adjusted dying and professionalism are important keywords. Finally: the costs for the 
caring at the end of life are low. If someone becomes a real burden for the society or if people 
have “out-lived themselves” (Thomas Morus), they decide on their own to die underlining the 
importance of the common good. There is no need for a governmental decision, because the 
people have internalized the ideals of a good life and death and decide on their own in the 
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correct manner. If patients have lost their decision making capacity, close friends or family 
members will decide for them in the normalized way. 
Desirable scenario for the near future 
Neither the first nor the second scenario would be attractive or reasonable. I think a desirable 
scenario for the near future has to take into account some serious social problems like the 
financing of social security, the scarcity of physicians and nurses, the problem of isolation of 
old people, the increase of chronic diseases and dementia, longevity and last but not least the 
growing social inequalities with regard to welfare in general, access to health care and life 
expectancy in particular. While dying in high income countries is more and more expensive, 
millions of people in low income countries don’t have access to basic health care and are 
dying without provision of professional care at the end of their life. From a moral point of 
view it is absolutely necessary to create new ways to enable access to basic health care and 
palliative care e.g. for people with AIDS in Africa, or the millions of people who are victims 
of migration forced by war, civil war, hunger and poverty. In a certain sense there is a 
necessity of a de-medicalization of dying in the high income countries, and an imperative to 
medicalise death and dying in the rest of the world. 
One major problem in our high income societies will certainly be the one-sided 
concentration of controlling the dying process and the idea of isolating or concentrating all 
negative aspects of human life (like pain, suffering, dependence on others, dementia, 
depression, impairments) in a very last period of life, which should be professionally 
controlled either by palliative care-experts or shortened by suicide. This worry doesn’t 
concern in the first place normative aspects of duties and rights but ideals about a good or 
flourishing life. In this view assisted suicide should be the general solution to prevent, to 
eliminate or to ban pain, suffering, dependence, dementia and all the other negative experien-
ces. The overseen fact is that all these aspects are part of our human condition and aren’t 
preventable. Human life without suffering would no longer be human life. If we take a look at 
the real world there are more and more people suffering from chronic diseases, a lot of people 
dependent on others (not only disabled people) and an increase of depressions and other 
psychiatric disorders. The result of establishing this “misleading idea” (to place all the 
negative experiences in a very last phase of life) therefore could only end in deception or 
premature death. Certainly there are questions without answer, we can struggle against 
diverse forms of pain and suffering, but suffering as human condition will stay and is to be 
endured (even if there is no meaning). An idealization of dying-processes often called 
“natural dying”, could collide with the common reality of alienations or inconsistencies 
during the dying process.  
Epicurus said in his letter to Menoeceus: “The art of living well and dying well are 
one.” [17, p. 45] In other words: An ars moriendi (art of dying) is identical to an ars vivendi 
(art of living), since in the last phase of life the very same aspects are of importance as during 
the whole life. From a Christian viewpoint I would underline the importance of the three 
divine virtues: belief, hope and love, furthermore the attitudes of forgiveness, acceptance of 
change and the fact that human life is always fragmentary and imperfect. In this view we 
should be at least skeptical regarding the idea of the “Ganzheitlichkeit” (totality or wholeness) 
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in palliative care, also about the idea of dying a perfect or mild death (“Sanftes Sterben” [18]). 
As Sherwin Nuland has pointed out, the material view of dying processes often shows neither 
a mild nor acceptable, but a tough and horrible picture. 
In this view an ars vivendi should encompass the rediscovering of acceptance of 
“fate”, in the sense of accepting the fact of being determined by others or by unforeseen 
events in life. In our human destiny, birth and death are peaks of heteronomy. The German 
philosopher Martin Seel reminds us (like Harry Frankfurt) about the one-sidedness of the 
ideal of a rationally organized and planned life (I’d like to add: also about the one-sided idea 
of a so called “rational suicide”): “They will only live autonomously, if they let themselves be 
surprised by the world, by others, and all the more by themselves.” [19, p. 629]2 
Furthermore an over-planned life could end up in a state of self-blockade. Even if 
advanced care can be useful we should accept that the final phase often can’t be completely 
controlled. A clenched orientation towards the planning and controlling of the dying process 
could end up in the opposite of a self determined death: in a rationally planned, socially 
enacted and for that deeply heteronomous dying, as Reimer Gronemeyer has stressed for 
years. He asks: „We have learned how to plan our lives. And now the planning of the dying 
comes along? Will modularization, standardization, quality check and evaluation be 
established in end of life care? Will we be delivered to a quality checked dying in the end?” 
[4, 22]3 
Finally I think we should accept and be open-minded to different ideas of what is or 
could be a good death. We should not forget that neonates, little children or the elderly with 
dementia couldn’t live up to the ideal of a self determined, self controlled death and that there 
are a lot of people who don’t want to write advanced directives. Allen Kellehear describes 
different concepts, narratives or pathways, besides the idea of dying as personal control. As 
important examples he mentions the understanding of dying as a journey, dying as oscillation 
(fluctuating between decline and improvements), dying as withdrawal (a process of 
disengagement, a slow withdrawal of both bodily energies and social engagement and 
interest), dying as physical collapse, disenfranchised dying (entrechtetes Sterben, stressing the 
powerlessness of the dying e.g. in nursing homes, but also underlining the fact of 
unrecognized dying like dying in prison, of AIDS, poverty, coma etc., not recognized by the 
dying themselves or by the authorities responsible for them) and finally dying as 
transformation (deathbed visions, near death experience nearly always full of love and peace). 
The subtitle of his book “The study of dying” is interesting and inspiring, indicating a change 
“From autonomy to transformation”. The sociologist writes: “Dying, like life itself, can still 
surprise us with the unexpected and the positive, often even in what seems to be our darkest 
hour.” [1, p. 17] 
                                                                
2  Im deutschsprachigen Original: „Autonom lebt nur, wer frei dafür ist, sich von der Welt, von den anderen 
und erst recht von sich selbst überraschen zu lassen.“ 
3  See also pp. 187–199: „Death Control. Von der Kunst des Sterbens zum verwalteten Abgang“: „Unser 
Leben zu planen, das haben wir gelernt. Kommt jetzt die Sterbeplanung dazu? Setzen sich in der 
Sterbebegleitung Modularisierung, Standardisierung, Qualitätskontrolle und Evaluation so durch, dass wir 
am Ende einem qualitätskontrollierten Sterben ausgeliefert sind?“ 
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death. Thoughts on death and dying in the future’. Some critical questions are raised about his 
analysis of present trends and the dystopic future scenarios that he envisages; in particular, it 
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about the goods at stake in our practices of death and dying, that conversation will need to be 
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I want to begin by expressing my thanks to Dr Zimmermann-Acklin for his wonderfully rich 
and interesting paper. I found much of his analysis of present trends and future scenarios very 
persuasive, and found myself very much in sympathy with a good deal of what he advocates 
in his final section. While I agree with much of what he has argued, however, I hope to be 
able to raise enough questions to prompt some fruitful further reflections. 
Let me begin with a few detailed questions about Dr Zimmermann-Acklin’s analysis 
of present trends and the two ‘extreme’ future scenarios he maps out. 
 
1. He claims that ‘the modern idea of understanding death as “enemy of life” is 
disappearing’, to be replaced by the project of controlling death s fully as possible. I 
wonder whether this over-states the case: certainly the theme of control has become 
more prominent, but how strong are the reasons for thinking that it is displacing the 
idea of death as an enemy? Is it possible to read this change as not so much a switch 
of attitudes as an intensification of the modern attitude: we still regard death as an 
enemy, to be hidden away in institutions and avoided as long as possible; but when 
we have to face it, we make sure we do so on our own terms? 
2. In current public debates about assisted dying, certainly in a British context, much of 
the rhetoric focuses on the unbearable pain, suffering or indignity of terminally or 
chronically ill patients, and that is where a good deal of the force of compassion-
based arguments in favour of assisted dying seems to come from.1 I wonder how 
much evidence there is that this desire to gain control over death in these extreme 
and apparently unbearable circumstances is part of a more general trend to want to 
choose death as an escape from ‘boredom, indifference and coldness’? 
3. I am not sure that the dystopic palliative care scenario is properly considered as a 
development or extrapolation from the current practice of palliative care: it might be 
better understood as a parody or distortion of that practice. The practice of palliative 
care, properly understood, might be quite hospitable to Dr Zimmermann-Acklin’s 
argument. Certainly, the way in which some palliative care professionals understand 
their work seems to me to embody some of the insights about the ars moriendi (and 
perhaps even the ars vivendi) that he advocates in the final section of his paper. This 
wisdom is discernible, I think, in part of the evidence given by the Association of 
Palliative Medicine in the UK to the House of Lords Select Committee on Lord 
Joffe’s Assisted Dying Bill in 2005. Responding to compassion-based arguments in 
favour of assisted dying as a way to end unbearable suffering, they said: 
Relief of suffering is an important goal of medical care. However, palliative care cannot, 
and does not claim to be able to relieve all suffering. There is no sort of care that could 
ever alleviate all suffering (especially some expressions of social, psychological and 
spiritual distress), but the first step to addressing the majority of this suffering is to ensure 
effective support and skilled interventions are available to those who require them, rather  
 
 
                                                                
1  As, for example, in many of the personal stories featured on the website of the campaigning organisation 
Dignity in Dying: http://www.dignityindying.org.uk/personal-stories.html (accessed 03 July 2012). 
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than introduce a way to end these individual's lives. The inability to relieve all suffering is 
inevitable and is part of the human condition.2 
In short, it seems to me that palliative care, rightly understood and practiced, could be 
part of the solution rather than part of the problem. And this leads me on to some more wide-
ranging issues that I think Dr Zimmermann-Acklin’s paper very helpfully and interestingly 
raises. 
He presents the assisted-dying and palliative-care scenarios as dystopias, and certainly 
I am quite ready to agree that they are dystopic. But how do we recognise them as dystopias? 
I can imagine that some of the participants in assisted dying debates in the UK, for example, 
might find both of them quite attractive. 
I think part of the answer comes right at the end of his section 3: we recognise it by 
paying attention to those who do not fit these scenarios and never will. If (for example) 
infants and little children, older people with dementia and the world’s poor have to be written 
out of the script in order to make the narrative of autonomous control over one’s dying work, 
that could be a sign that something has gone badly wrong: that a project motivated by the 
most humane of impulses turns out to entail commitments a good deal less humane than the 
best motivations of its advocates. 
If I am right about that, perhaps it signals that acceptance of the ‘realistic and 
desirable’ future scenario which Dr Zimmermann-Acklin advocates in his final section would 
require some fairly large shifts in the moral ‘landscape’ of our societies and cultures. To 
mention a couple of examples, again from a British context: I have argued elsewhere that the 
notions of ‘autonomy’ and ‘compassion’ that dominate current public debates about assisted 
dying have some highly problematic features, and require – at the least – some fairly radical 
re-framing if our shared deliberation about assisted dying is not to be seriously distorted.3 So 
it may be that the ‘realistic and desirable’ scenario (which I for one would endorse 
wholeheartedly) will require some quite radical re-thinking of some of our cultures’ basic 
assumptions, if it is to seem either realistic or desirable to our societies. 
And that brings me to the ars moriendi and the ars vivendi. Again, I am very much in 
agreement with Dr Zimmermann-Acklin’s argument, but it raises an interesting question: 
when we talk about the ars moriendi and the ars vivendi, we are referring to a tradition that 
presupposed a transcendent horizon; what it said about both living and dying was shaped by 
its convictions about the ultimate, supernatural end of human life. This is elegantly expressed 
in some lines from a famous evening hymn by the seventeenth century English bishop 
Thomas Ken (1637—1711): 
Teach me to live that I may dread 
The grave as little as my bed; 
 
                                                                
2  Select Committee on the Assisted Dying for the Terminally Ill Bill, Report on the Assisted Dying for the 
Terminally Ill Bill, 2005—06, HL Paper 86-I—III, vol. II: Evidence, p. 141, online at 
www.publications.parliament.uk/pa/ld/ldasdy.htm (accessed 27 July 2012). 
3  Messer, Neil, Respecting Life: Theology and Bioethics, London: SCM Press, 2011, pp. 212—27. 
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To die, that this vile body may 
Rise glorious at the awful day.4 
So the question is whether our societies and cultures can re-learn what they need to of 
the ars moriendi and the ars vivendi, if they have largely lost sight of the transcendent horizon 
that made sense of those arts. And if our societies are to re-learn these things, how are they to 
do so? 
Some Christian theologians and ethicists suggest that religiously plural liberal 
societies cannot learn these things. The Orthodox Christian bioethicist H. Tristram 
Engelhardt, for instance, holds that ‘Orthodox Christian bioethical insights be adequately 
shared with others outside of the common life sustained by a pursuit of salvation in right 
worship and right belief, because only through and within such a life of right worship and 
right belief can one rightly experience the Holy.’5 Conversely, some philosophers and 
political theorists argue that liberal societies should not attempt to put back in place the kind 
of transcendent horizon that (I have suggested) makes the ars moriendi and ars vivendi 
intelligible. Mary Warnock, for example, has argued that, although religious people who are 
well-informed and morally serious can make a valuable contribution to public policy debates, 
religious arguments should not influence policymaking in societies that are not theocracies.6 
It will be noticed how neatly these two views complement one another, providing 
justifications from inside and outside a Christian theological tradition for leaving the 
boundary between ‘inside’ and ‘outside’ undisturbed. But I am not persuaded by the ‘insider’ 
argument for leaving the boundary undisturbed. Christians have theological reasons to care 
how ethical and political decisions are made in the wider society beyond the bounds of their 
communities of faith: political life in the world forms part of what Dietrich Bonhoeffer called 
the ‘penultimate’ realm, which is given a new validity and importance in theological 
perspective in the light of God’s ‘ultimate’ saving work.7 They also have theological reasons 
for thinking that some of the things they wish to say will resonate with those outside their 
own communities.8 I am also unpersuaded by the ‘outsider’ argument for leaving the 
boundary undisturbed, because I suspect that the exclusion of religious or theological 
arguments from the public sphere will not mean that policy decisions are made on religiously 
                                                                
4  Ken, Thomas, ‘An Evening Hymn’, in Bishop Ken’s Christian Year: or, Hymns and Poems for the Holy 
Days and Festivals of the Church, London: Basil Montague Pickering, 1868, pp. 3—4. Online at 
http://archive.org/details/christianyearorh00kent (accessed 9 June 2012). The second couplet alludes to the 
Authorised (King James) Version’s translation of Philippians 3.21: ‘Who shall change our vile body, that it 
may be fashioned like unto his glorious body ...’. In modern hymnals, this verse is usually rewritten to omit 
the phrase ‘this vile body’, presumably to reflect a shift in usage since the seventeenth century that is also 
reflected in more recent translations of the biblical text (e.g. ‘He will transform the body of our humiliation 
[or our humble bodies] so that it may be conformed to the body of his glory’, New Revised Standard 
Version). 
5  Engelhardt, H. Tristram, Jr. ‘Orthodox Christian Bioethics: Some Foundational Differences from Western 
Christian Bioethics’, Studies in Christian Ethics Vol. 24 Issue 4, 2011, pp. 487—499 (494). 
6  Warnock, Mary, ‘Public Policy in Bioethics and Inviolable Principles’, Studies in Christian Ethics Vol. 18, 
Issue 1, 2005, pp. 33–41 (41).   
7  Bonhoeffer, Dietrich, Ethics. Dietrich Bonhoeffer Works, Vol. 6, English trans. ed. by Clifford J. Green, 
Minneapolis, MN: Fortress, 2005, pp. 146—170. See further Messer, Respecting Life, ch. 2. 
8  See further Messer, Respecting Life, pp. 212—27. 
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neutral grounds that can in principle command universal agreement; rather, they are likely to 
embody some substantive vision of the human good that tends to exclude or marginalize those 
perspectives that have been ‘left at the door’.9 
Other Christians will be more optimistic about the prospect that the wisdom embodied 
in the ars moriendi and ars vivendi will be recognizable and rationally persuasive to any 
person of goodwill. This optimism would be supported, for example, by the kind of Catholic 
perspective which holds that ‘the fundamental moral principles of Christianity are accessible 
to human reason, without reliance on revelation’.10 I wonder, though, whether this optimism 
does justice to the distinctiveness of the convictions underpinning that wisdom, and the extent 
to which those convictions will appear surprising and counter-cultural in many contemporary 
Western contexts. My suspicion is that if we are to open up a serious public conversation 
about the insights to be found in the ars moriendi tradition, we shall need to take the 
seemingly offensive step of bringing God into the discussion. There are good reasons to think 
that so far from stultifying public debates, as ‘secularists’ might fear, such a surprising move 
could enrich and inform those debates: as Nigel Biggar has argued, theological arguments are 
well able to ‘behave in public’ and have as much title as other forms of argument to be taken 
seriously as exercises in public reason.11 
In short, perhaps not surprisingly, questions about our societies’ laws and practices in 
relation to death and dying quickly lead us on to a very big conversation about the ends and 
goals that it is good for human people and communities to pursue – the kind of conversation 
that liberal societies often imagine they cannot or should not try to have. It certainly seems to 
me that my own society has not been very good at having that conversation in relation to 
death and dying in recent years. But I think we have to find ways of having it, because if we 
do not, we shall not avoid answering the questions that it raises: we shall simply find 
ourselves choosing some answers rather than others unexamined and by default. 
                                                                
9  See further MacIntyre, Alasdair, Whose Justice? Which Rationality? London: Duckworth, 1988. 
10  Report on the Assisted Dying for the Terminally Ill Bill, Vol. II, p. 704. 
11  Biggar, Nigel, Behaving in Public: How to Do Christian Ethics. Grand Rapids, MI: Eerdmans, 2011. 
